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ABSTRACT 
The development of systematic evolution of ligands by exponential 
enrichment, or SELEX, in 1990 propelled interest in nucleic acid engineering. The 
ability of nucleic acids to undergo directed evolution has resulted in the widespread 
interest in the development of aptamers, or single stranded nucleic acids that 
possess affinity to a specific target molecule.  Aptamers exist to diverse classes of 
molecules, and because of their versatility are being regarded as robust 
recognition elements for a variety of biotechnology applications. Further, the small-
molecule harnessing potential of aptamers has shown great promise for the 
development of biosensors. Importantly, traditional selection methods can be 
expanded upon to enable the generation of functional nucleic acids which are 
optimized for biosensing platforms.  
Novel SELEX methods are a powerful tool to develop innovative 
technologies for detection and imaging using aptamer-based biosensors. Our lab 
has contributed to a variety of areas within this field including the use of ribozymes 
as a tag for intracellular imaging of RNA. We have designed a novel IP-SELEX 
method which allows for the generation of ribozymes that are capable of 
performing a reaction to covalently attach a small-molecule fluorophore to itself 
(Chapter 2). We show that this ribozyme can label in cellular conditions and hold 
great promise as a genetically encodable tag for live cell labeling of mRNA.
iv 
We have also developed a new class of small-molecule sensors through 
the evolution of nucleic acids with noncanonical backbone structures, or xeno 
nucleic acids (XNA). XNA molecules have many advantageous properties 
because of their noncanonical structures, notably nuclease resistance. Using our 
unique method, optimized by the use of an XNA primer, we were able generate 
the first artificial genetic polymers capable of small-molecule recognition (Chapter 
3). We discovered threose nucleic acid (TNA) aptamers with affinity for a small-
molecule mycotoxin (OTA). We show that these aptamers have outstanding 
biostability in the presence of nucleases and retain the ability to bind the target in 
these environments. 
We acknowledge the potential for structure-switching (SS) aptamer 
biosensors as a privileged architecture for small-molecule detection and the 
development of fluorescence assays. We propose an innovative technique for the 
direct selection of SS biosensors, in which we take advantage of both restriction 
digests and polymerase chain reaction (PCR) as key steps to eliminate 
nonfunctional sequences. Importantly, because amplification simultaneously 
serves as the selection step there is no requirement for a solid support. We 
anticipate this will overcome the limitations of bead-based selection methods and 
enable for efficient and effective generation of SS biosensors. 
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CHAPTER 1 
APTAMERS WITH UNIQUE PROPERTIES 
AND FUNCTION  
Introduction*
Nucleic acids are best known for their ability to encode, store, and decode 
genetic information in cells. However, the functional capacity of DNA and RNA 
stretches far beyond information storage to encompass complex tasks such as 
regulation and catalysis. These capabilities have emerged as a result of evolution 
over millions, or even billions, of years. Inspired by the ability of evolution to provide 
nucleic acids having this large diversity of functions, researchers have sought to 
replicate the evolutionary process in the laboratory. In 1990, the Szostak, Joyce, 
and Gold labs individually reported the successful implementation of selection and 
evolution in vitro, and this process was termed Systematic Evolution of Ligands by 
EXponential enrichment (SELEX).1-3 Over the past 25 years, SELEX has been 
most broadly applied for the in vitro evolution of aptamers, which are nucleic acid 
sequences capable of binding to specific small-molecule or protein targets. Using 
the SELEX process, functional nucleic acid sequences can be enriched and 
*Adapted from Methods, Vol. 106, Meek, K. N.; Rangel, A. E.; Heemstra, J. M.,
Enhancing aptamer function and stability via in vitro selection using modified nu-
cleic acids, Pages 29-36, Copyright 2016, with permission from Elsevier.
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evolved from a starting library on the time scale of days, providing a powerful route 
to rapidly generate biopolymers having new capabilities.4 To date, over 1000 well-
characterized aptamers to over 550 target molecules have been reported in the 
literature, demonstrating the broad interest of the research community in this class 
of reagents.5  
In addition to providing functional sequences on a dramatically accelerated 
timescale, in vitro selection also benefits from the fact that the building blocks for 
evolution and the resulting biopolymers can be chemically synthesized, increasing 
the diversity of structural space that can be explored. Specifically, the sugar- phos-
phate backbone can be modified to render aptamers resistant to nuclease cleav-
age, and in some cases, increase affinity for the specified target.6 Alternatively, the 
nucleobases can be modified to expand the functional scope of the aptamers, 
providing similar affinity to antibodies, which benefit from the functional diversity of 
the naturally occurring amino acids.7 Early examples of nonnative nucleic acid ap-
tamers were primarily generated via postselection modification. In this process, the 
aptamer was first selected using native DNA or RNA, then modifications were sys-
tematically introduced and their impact on affinity, stability, and function quantified. 
A classic example of this approach is the drug Macugen (pegaptanib), which is 
FDA approved for the treatment of age-related macular degeneration, and repre-
sents the first aptamer-based therapeutic to be successfully commercialized.8  
The development of Macugen began with the use of SELEX to generate an 
RNA aptamer for the vascular endothelial, which regulates blood vessel growth in 
the eye, and thus is a primary target for the treatment of age-related macular dege- 
	 3 
neration.9 After identification and truncation of the initial aptamer sequence, a num-
ber of modified sequences having 2’-O-Me, 2’-NH2, and 2’-F modifications were 
generated and tested (Figure 1.1a).10 Modifications to the termini of the aptamer 
were also investigated as a method for increasing stability and circulation lifetime.6 
As a result of these modifications, the affinity, IC50, and biological half-life were 
each improved by orders of magnitude, and the optimized aptamer structure was 
carried forward into testing and approved as Macugen (Figure. 1.1b).  
 While the story of Macugen highlights the potential gains that can be real-
ized through postselection modification of aptamers, an even more powerful ap-
proach is the direct selection of aptamers from libraries bearing modified back-
bones or nucleobases. In this approach, a large number of modified sequences  
 
Figure 1.1.  Backbone modifications used in postselection testing of anti-VEGF165 
aptamer. (a) Chemical structure of RNA and modified backbones. (b) Sequence of 
Macugen. Red Letters with circles are 2’-F pyrimidines and blue letters with 
squares are 2’-O-Me purines. 
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can be investigated in parallel, and the most effective modifications are directly 
enriched in the selection process, in contrast to the trial-and-error process of post-
selection modification. As a result, aptamers having unique and improved function 
can be generated in shorter amounts of time. For several years, a key challenge 
preventing realization of this goal was the incompatibility of modified building 
blocks with the polymerases used to transcribe, reverse transcribe, or amplify nu-
cleic acids during SELEX. However, over the last decade, exciting progress has 
been made in two key areas: (1) the development of engineered polymerases ca-
pable of utilizing nonnatural building blocks as substrates, and (2) the invention of 
clever strategies for the nonenzymatic templated synthesis of modified nucleic ac-
ids, which eliminates the need for polymerases to accept the non-native nucleic 
acids as substrates. This review will highlight many of these recent developments, 
and explore their application for in vitro selection of modified nucleic acid aptamers. 
The review is organized into two main sections, which separately address the se-
lection of aptamers having modified backbones and modified nucleobases. These 
two different types of modifications create different challenges for the implementa-
tion of SELEX, and thus have required slightly different forms of technology devel-
opment. Excitingly, the progress that has been made in each of these areas has 
provided a key foundation for the development of in vitro selection methods that 
combine both backbone and nucleobase modifications, which will enable the future 
exploration of even greater swaths of structural and functional space.  
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SELEX using backbone-modified nucleic acids 
 Aptamers have found use in a wide variety of applications including bio-
sensing, affinity purification, therapeutics, and biological targeting. However, the 
low biological stability of DNA and RNA can pose limitations for the use of ap-
tamers in these applications.11 Because DNA and RNA are naturally occurring bi-
omolecules, a number of nuclease enzymes have co-evolved to catalyze their deg-
radation, which becomes especially problematic for the use of aptamers in vivo. 
Modification of the nucleic acid backbone can greatly reduce nuclease susceptibil-
ity, and this strategy has been successfully implemented to enable the use of nu-
cleic acids in antisense therapy and targeted drug delivery. These backbone-mod-
ified nucleic acids are generally referred to as xeno nucleic acids (XNAs), where 
the ‘‘X” can be replaced by a specific letter (or letters) to indicate a particular mod-
ification (Figure 1.2). Also included in Figure 1.2 is L-DNA, which is the enantiomer 
of native D-DNA. L-DNA differs from XNAs in that it does not have a chemically 
modified backbone. But, due to its chiral modification, we still choose to classify L- 
DNA as a modified nucleic acid. For antisense applications, XNA oligonucleotides 
having the desired activity can be generated with relative ease, as their activity 
relies upon Watson–Crick base pairing, and thus function is only minimally per-
turbed by the introduction of modifications.12 However, as outlined above, postsyn-
thetic modification of aptamers is significantly more challenging and time-intensive. 
A preferable approach is the direct selection of aptamers from XNA libraries, but 
this introduces new challenges, as the backbone modifications that prevent recog-
nition by nucleases also make recognition by polymerases less efficient. Excitingly, 
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Figure 1.2. Chemical structure of XNA backbones that have been explored for in 
vitro selection experiments.  
great strides have been made recently in the field of polymerase engineering, 
which has enabled the development of polymerases that can both encode (tran-
scribe) DNA into XNA, and decode (reverse transcribe) XNA back into DNA, ena-
bling selection of aptamers from XNA libraries. This section will discuss the imple-
mentation of these engineered polymerases for the in vitro selection of XNA ap-
tamers, and will highlight recent exciting developments in the area of nonenzymatic 
templated synthesis, which holds promise to eliminate the reliance on enzymes for 
encoding and decoding of sequences during SELEX.  
Mirror-image selection of L-DNA aptamers 
While postselection incorporation of chemically modified nucleotides is 
challenging, one unique class of XNA for which postselection modification is rela-
tively trivial is L-DNA. Because it is the mirror image of naturally occurring D-DNA, 
these aptamers can be initially selected using standard DNA SELEX against the 
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enantiomer of the desired target. Then, the resulting sequences can be chemically 
synthesized from enantiomeric L-DNA, and due to the principal of reciprocal chiral 
substrate selectivity, they will bind to the desired target with identical affinity and 
specificity as the initially selected aptamer. The Joyce Lab has been a key pioneer 
in the selection of L-DNA aptamers, and recently reported an L-DNA sequence 
that utilizes non-Watson-Crick interactions to bind to the HIV-1 trans-activation re-
sponsive (TAR) RNA.13 The Klussman Lab have also been key pioneers of mirror-
image selection, and have recently implemented this process to generate a D-RNA 
sequence capable of binding to the enantiomer of complement factor C5a, a pro-
inflammatory mediator involved in the pathogenesis of many inflammatory dis-
eases. Interestingly, after minimization of the D-RNA sequence, the aptamer was 
then synthesized using a mixture of L-DNA and L-RNA monomers and was found 
to bind the target with high efficiency.14 While this approach significantly benefits 
from the fact that selections are carried out using native DNA or RNA, a minor 
drawback is the need to generate the enantiomer of the target for use in the selec-
tion experiments. In the case of small molecules and peptides, this is typically not 
problematic. However, generating an enantiomeric target can become challenging 
when undertaking selections for large proteins that are not amenable to chemical 
synthesis.  
Selection of XNA aptamers using engineered polymerases 
As described above, a key challenge for the selection of XNA aptamers is 
that XNA nucleotides can be poor substrates for naturally occurring polymerases. 
However, a number of groups have devoted significant effort to screening comer- 
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cially available polymerases, and at times engineering new polymerases, in order 
to efficiently encode and decode XNA sequences during the SELEX process.  
Selection of XNA aptamers using polymerase- 
mediated encoding 
 One particularly promising XNA for use in biological applications is threose 
nucleic acid (TNA), which has been shown by Chaput and coworkers to possess 
excellent nuclease resistance.15 The commercially available Therminator DNA pol-
ymerase (NEB) was found to be capable of encoding (transcribing) DNA libraries 
into TNA, at least in the context of TNA sequences having T, G, and diaminopurine 
(D, used in place of adenine) nucleotides.16 Thus, the Chaput Lab designed a 
‘‘DNA display” selection strategy that obviates the need for a decoding (reverse 
transcription) step, enabling the implementation of a full SELEX cycle (Figure 1.3a). 
To achieve this, a DNA hairpin was designed that contains both the library template 
and primer, and thus can be used to synthesize a TNA library via primer extension 
using Therminator. A DNA primer was then annealed in the loop region of the hair-
pin, and extension of this primer displaced the TNA, ‘‘displaying” it on a DNA du-
plex where it could then be screened for binding to the target molecule. Using this 
strategy, the genetic information of each TNA strand is maintained in the covalently 
attached DNA template, which can be directly PCR amplified after selection, cir-
cumventing the need to decode the selected XNA sequences. Using this strategy 
coupled with capillary electrophoresis to separate target-bound and free se-
quences, the Chaput Lab successfully selected a thrombin-binding TNA aptamer-
having a KD value of 200 nM. They have since shown that incorporation of 7- 
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Figure 1.3. Selection of XNA aptamers using engineered polymerases. (a) “DNA 
display” strategy only requires a polymerase for encoding the DNA library into XNA. 
(b) Two-enzyme selection system enables both encoding and decoding of XNA,
so selection step can be carried out using single-stranded XNA library.
deazaguanine in the DNA template allows for the transcription of four-letter TNA 
libraries, which will enable the selection of TNA aptamers that take advantage of 
the full scope of Watson-Crick base pairing.18 Additionally, the Chaput Lab have 
recently discovered that commercially available SuperScript II polymerase is ca-
pable of reverse transcribing TNA into DNA, which will enable selections to be 
carried out in a manner analogous to RNA SELEX.18  
Selection of XNA aptamers using polymerase-mediated 
encoding and decoding 
A key advance in the selection of XNA aptamers was realized with the de-
velopment of compartmentalized self-tagging (CST) by Holliger and coworkers, 
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which enables the rapid evolution of polymerases for XNA substrates.19 Using this 
method, a series of enzymes was evolve that are collectively capable of both tran-
scription and reverse transcription of 1,5-anhydrohexitol nucleic acid (HNA), cyclo- 
hexitol nucleic acid (CeNA), 2’-O,4’-C-methylene-b-D-ribonucleic acid (locked nu-
cleic acid, LNA), aribinonucleic acid (ANA), 2’-fluoro-arabino-nucleic acid (FANA), 
and TNA (Figure 1.2). Because these enzymes are capable of both encoding and 
decoding XNA libraries, SELEX can be can carried out as shown in Figure 1.3b. 
Much like RNA SELEX, XNA selections using encoding and decoding polymerases 
begin with generation of an XNA library via transcription from a DNA library. Once 
purified away from the DNA template, a selection step can be employed to enrich 
the XNA library for sequences having the desired function, and these sequences 
can be reverse-transcribed back into DNA for amplification or sequencing.  
Using the encode-select-decode strategy coupled with a standard bead-
based enrichment method, Holliger and coworkers used their engineered polymer-
ases to generate HNA aptamers for both HIV TAR RNA and Hen Egg Lysozyme 
(HEL).20 Both aptamers bind to their intended targets with good selectivity and KD 
values in the nanomolar range. Similarly, DeStephano and coworkers used CST-
derived polymerases to select for a FANA aptamer that binds to HIV-1 reverse 
transcriptase (RT) with picomolar affinity.21 This affinity was higher than that 
achieved by a DNA aptamer for the same target, demonstrating that XNA back-
bones can also provide increased affinity for the target, potentially through energ- 
etically favorable hydrophobic interactions. Interestingly, the enzyme used to tran-
scribe DNA into FANA not only functions as an isothermal primer extension cata- 
11 
lyst, but can also be employed in thermal cycling protocols similar to those used in 
PCR, suggesting that direct amplification of XNA may be possible in the future.  
Taking a slightly different approach, Kuwahara and coworkers utilized an 
engineered polymerase for LNA, but the primer used for the encoding step was 
comprised of DNA having LNA inserted at every third nucleotide. Similarly, the 
libraries that were generated were primarily composed of DNA, but had all thy-
mines replaced with locked thymine analogues. Using this library of chimeric 
DNA:LNA sequences, four thrombin-binding aptamers were selected via capillary 
electrophoresis, and were found to have KD values of 18, 20, 23, and 27 nM.22,23   
Nonenzymatic templated synthesis of genetically 
encoded libraries 
The selection methods described up to this point rely on engineered poly-
merases to encode and decode XNA sequence information. Liu and coworkers 
envisioned that the information stored in a DNA template could potentially be en-
coded into XNA, or even nonnucleic acid polymers without the use of enzymes, 
which would dramatically expand the structural diversity that could be explored in 
selection experiments. This principle was initially demonstrated for peptide nucleic 
acid (PNA), which is capable of Watson-Crick base pairing with DNA and RNA24 
but does not possess a phosphodiester backbone, and thus cannot be generated 
using even highly engineered polymerases. Similar to the encode-only ‘‘display” 
strategy, a self-priming DNA hairpin was used as a template, and PNA building 
blocks having sequences complementary to this template were annealed and cov- 
alently polymerized using reductive amination. To illustrate the potential utility of 
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this method for in vitro selection, a mock selection was performed in which one 
PNA building block was synthesized having a biotin, and sequences containing 
this building block were enriched from a random pool.25  
Taking one step further, Liu and coworkers envisioned that templated syn-
thesis could be used to generate libraries of sequence-defined polymers that have 
no inherent affinity for the DNA template. This was accomplished using a design 
inspired by the ability of tRNAs to mediate the templated synthesis of peptides. As 
shown in Figure 1.4, PNA building blocks similar to those used in their previous 
experiments were equipped with a nonnucleic acid polymer segment via two cleav-
able linkers. In this case, the functional groups required for ligation were placed on 
the nonnucleic acid polymer, which enabled templated ligation of these segments 
to create the genetically encoded polymer. Subsequent cleavage of the linkers res- 
Figure 1.4. Nonenzymatic templated polymerization of nonnucleic acid polymers. 
Polymer segments are covalently attached to an “adaptor” nucleic acid fragment, 
which directs templated polymerization, but can be subsequently cleaved to reveal 
the encoded polymer library.  
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ulted in removal of the PNA adapter segments, allowing the polymer to be cova-
lently displayed on its encoding DNA sequence.26 While these templated polymer-
ization strategies have yet to be successfully employed in the selection of ap-
tamers, there is significant promise in their ability to encode genetic information 
into a structurally diverse range of sequence-defined polymers. 
SELEX using modified nucleobases 
Proteins have historically dominated the pool of available catalysts and af-
finity reagents, likely as a result of the diverse array of amino acid side chains that 
they can employ. In contrast, DNA and RNA are each comprised of only four nu-
cleotide building blocks, and these all possess a relatively similar palette of func-
tional groups. Aiming to generate aptamers that have similar affinity and specificity 
to protein-based receptors, a number of research groups have explored the in vitro 
selection of aptamers using monomers having unnatural nucleobases. The earliest 
example of SELEX using modified nucleotides was presented by Toole and 
coworkers in 1994, where an aptamer for thrombin was generated using a library 
in which all thymine monomers were replaced by 5-pentynyl-dU.27 This aptamer 
was found to have a dissociation constant comparable to that of a previously se-
lected DNA aptamer for thrombin, and showed unique secondary and tertiary 
structures. While this early example established precedence for the idea of utilizing 
unnatural nucleobases in SELEX, the true potential of this approach was demon-
strated later by SomaLogic, Inc., who carried out selections in which thymine was 
replaced with a 2’-deoxyuridine (dUTP) having a hydrophobic functional group at 
the 5’ position of the nucleobase.28 Using libraries containing these monomers, 
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high-affinity ‘‘SOMAmers” were generated for a number of challenging targets, and 
were subsequently incorporated into an aptamer-based biomarker detection plat-
form capable of detection limits in the fM range. The exploration of SELEX using 
unnatural nucleobases has rapidly expanded in the past few years, and these ef-
forts can be separated into two general approaches: (1) development of unnatural 
base pair systems that are orthogonal to the Watson-Crick base pairs, and (2) 
addition of peptide-like functional groups to native nucleobases. As is the case for 
in vitro selection using modified backbones, a key challenge to the use of unnatural 
nucleobases in SELEX is the requirement that the unnatural nucleotides be en-
coded and decoded during the selection process, and this often requires compat-
ibility with polymerases. In the case of modified nucleobases, and additional chal-
lenge is that the selectivity of base pairing with or between modified bases must 
occur with high fidelity during the encoding and decoding steps. However, a variety 
of innovative methods have been recently developed to circumvent these chal-
lenges and expand the scope of nucleobase modifications that can be employed 
for the in vitro selection of aptamers.  
Development of unnatural base pairs 
 Expansion of the genetic alphabet to include base pairs beyond naturally 
occurring A:T/U and G:C was first pioneered by Alex Rich in 1962, with his pro-
posal that an orthogonal base pair could be formed between iso-G and iso-C.29 
The key requirements for the development of these new base pairs was that the 
two modified nucleobases must pair with one another, but not with the canonical 
nucleobases. Following up on this initial work, Benner and coworkers proposed 
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three non-canonical donor–acceptor patterns, which could in principle be used in 
conjunction with the two Watson-Crick base pairs to provide an artificially ex-
panded genetic information system (AEGIS) having five different base pairs.30  
Taking a different approach to the design of unnatural base pairs, the Kool, 
Romesberg, and Hirao groups have each reported modified nucleotides that are 
able to form orthogonal base pairs through hydrophobic interactions rather than 
hydrogen bonding.31-33 While these base pairs have been utilized for a number of 
innovative applications over the past several years, only recently have the techno-
logical hurdles required for their use in aptamer selections been overcome.  
Aptamer selection using base pairs having alternative 
hydrogen bonding patterns 
In the design of the AEGIS base pairs, the Benner Lab hypothesized that 
placing electron density on the minor groove face of each nucleobase would ena-
ble recognition by polymerases, allowing the enzymatic synthesis and amplifica-
tion of oligonucleotides incorporating the AEGIS base pairs.34 Among the pro-
posed AEGIS base pairs, this requirement was most efficiently met by pyrimidine 
donor-donor-acceptor (pyDDA) and purine acceptor-acceptor- donor (puAAD) mo-
tifs. From this insight, the Z:P base pair was reported in 2006 (Figure 1.5), and was 
shown to be highly specific, exhibiting orthogonality to the natural nucleobases and 
having a favorable effect on overall duplex stability. Moreover, the Z-P base pair 
was recently confirmed to adopt Watson-Crick geometry, supporting the genera-
tion of a six nucleotide genetic alphabet.35  
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Figure 1.5. Natural and unnatural DNA base pairs used for the in vitro selection of 
aptamers. The Z:P base pair utilizes an orthogonal donor-acceptor hydrogen bond-
ing pattern, whereas the Ds:Px base pair relies on hydrophobic interactions. 
 Equipped with an unnatural base pair that was capable of enzymatic ampli-
fication, Benner and coworkers turned to exploring the use of Z:P in the selection 
of aptamers. Using a library containing a 1.5:1.2:1.0:1.0:1.0:0.5 ratio of 
T:G:A:C:Z:P, SELEX experiments were carried out against the MDA-MB-231 
breast cancer cell line.36 Because the AEGIS base pair is recognized by native 
polymerases, sequences that bound to the target cells were able to be directly 
PCR amplified using all six nucleotide triphosphates, and the resulting oligonucle-
otides carried into the subsequent selection round. After 11 rounds of selection, 
the resulting library was sequenced by dividing it into two fractions, which were 
independently barcoded. For each fraction, the Z and P nucleotides were con-
verted into natural nucleotides using a different protocol. In the first fraction, the Z 
and P nucleotides were converted to C and G, respectively. In the second fraction, 
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the Z nucleotides were converted to a mixture of C/T and the P nucleotides were 
converted to a mixture of A/G. These two fractions were then combined and sub-
jected to next-generation sequencing, and alignment of the resulting sequences 
revealed the locations of the unnatural nucleotides in the selected pool. The dom-
inant aptamer was found to have a binding affinity of 30 nM, and replacement of 
the Z:P base pairs with Watson-Crick base pairs greatly diminished this affinity, 
highlighting the important role of these modified nucleotides in the target-binding 
interaction.  
Aptamer selection using hydrophobic base pairs 
In 2006, Hirao and coworkers introduced the Ds:Pa hydrophobic base pair, 
and showed that the unnatural nucleotides could serve as substrates for natural 
polymerases.33,37 While the Ds-Pa system was successful in both replication and 
transcription experiments, in part owing to the unique shape complementarity be-
tween the hydrophobic bases, undesired Ds-Ds and A-Pa base pairs were ob-
served, leading to reduced fidelity. Subsequently, 2-nitro-4-propynylpyrrole (Px) 
was synthesized as an optimized pairing partner for Ds, having nitro and propynyl 
groups to alter electrostatic interactions and increase hydrophobicity, respectively 
(Figure 1.5).38 The increased hydrophobicity of Px improved incorporation opposite 
Ds, suppressing Ds-Ds mispairing, and the electrostatic repulsion due to the nitro 
group discouraged A-Px mispairing.  
Using the Ds:Px unnatural base pair system, aptamer selection experi-
ments were carried out against vascular endothelial cell growth factor(VEGF165) 
and interferon-g (IFN-g).7 The hydrophobicity of Ds was hypothesized to improve 
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interactions with hydrophobic regions of the protein targets, and to ensure access 
of the unnatural nucleotides to the protein target, Px was intentionally left out of 
the library, as this prevented the enrichment of meaningful sequences in which the 
Ds was sequestered into base pairs. Unlike the Benner Z:P unnatural base pair, a 
convenient method for decoding the Ds:Px pairs after selection was not available. 
Thus, libraries were synthesized having 1–3 Ds nucleotides at fixed locations in 
the sequence, and these libraries were barcoded using a unique 2–3 nucleotide 
tag. The libraries were incubated with each protein target, and bound sequences 
were amplified in the presence of Ds and Px deoxyribonucleotide triphosphates 
(dDsTP and dPxTP) to prepare material for the subsequent selection round. After 
completion of the selection rounds, the libraries were amplified in the absence of 
dDsTP and dPxTP, which caused reversion of the unnatural base pairs to A:T base 
pairs, which could then be sequenced. As a control, selections for the two protein 
targets were also carried out using libraries having entirely native DNA nucleotides 
(contVG and contIF). The highest affinity aptamers for VEGF165 and IFN-g  from 
the Ds –modified library had KD values of 1.69 pM and 0.124 pM respectively. 
These affinities were dramatically higher than those obtained for control aptamers 
contVG (370 pM) and contIF (3 nM) for binding to VEGF165 and IFN-g respectively. 
Compared to the AEGIS approach, the Ds:Px base pair provides hydrophobicity 
that is generally lacking in the natural nucleobases, and the power of this is re-
flected in the high affinities obtained by the Hirao Lab. However, the current minor 
limitation of the Ds:Px base pair relative to AEGIS is that the sites of the Ds modi-
fications must be fixed in the sequence, compared to the Z:P nucleotides, which 
19 
can be distributed randomly throughout the library and decoded post-selection us-
ing sequencing.  
Modified nucleotides having peptide-like functional groups 
While aptamers have a number of benefits relative to antibodies, including 
increased thermal stability and their ability to be chemically synthesized, antibod-
ies benefit significantly from the chemical diversity available in the repertoire of 
naturally occurring amino acid side chains. In the early 2000s, it was envisioned 
that grafting the functional groups present in amino acid side chains onto DNA 
nucleobases could lead to the evolution of aptamers or DNA enzymes (DNAzymes) 
having new or improved function. In 2001, Perrin and coworkers utilized a library 
containing nucleobases modified with imidazole and amine side chains to generate 
a DNAzyme that functioned as an RNaseA mimic, and they later expanded these 
selections to include nucleobases having guanidine functional groups.39,40 Selec-
tions using a library containing a combination of imidazole, amine, and guanidine 
modifications resulted in the generation of a DNAzyme capable of cleaving RNA 
at rates much higher than previously reported for unmodified DNAzymes. Moreo-
ver, this modified DNAzyme maintained function in the absence of divalent metal 
cations, which are typically required for catalytic nucleic acids. These experiments 
demonstrated that the addition of protein-like functional groups could greatly en-
hance the potential catalytic abilities of nucleic acids. In parallel with the efforts of 
the Perrin Lab, Famulok and coworkers demonstrated that DNA sequences could 
be enzymatically polymerized in which all four nucleotides were substituted with 
an unnatural functional group, paving the way for in vitro selection using libraries 
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having a high density of amino acid-like functional groups.41 While these specific 
libraries have yet to be utilized for aptamer selection experiments, the knowledge 
of which positions on the nucleobases can be modified without disrupting enzy-
matic polymerization proved to be critical for the selection of nucleobase-modified 
aptamers such as SOMAmers. Additionally, in recent years, innovative methods 
have been developed to further expand the diversity of functional groups that can 
be appended to nucleobases for in vitro selection.42,43  
Nucleic acids as scaffolds for peptide display 
 While polymerase-mediated incorporation of modified nucleotides is a pow-
erful approach for the selection of functionalized aptamers, Liu and coworkers rec-
ognized that a greater diversity of side chains could be accessed via enzymatic 
templated synthesis of modified oligonucleotides. Specifically, they constructed tri-
nucleotide building blocks in which one nucleobase was functionalized with a side 
chain, and demonstrated that these could be efficiently polymerized on a DNA 
template using T4 DNA ligase.44 To demonstrate the potential of this technology 
for in vitro selection, a mock selection was carried out in which one building block 
was functionalized with a known ligand for carbonic anhydrase II.  
 Building upon this work, Hili and coworkers have investigated the use of 
building blocks having polypeptide side chains, as this would provide nucleic acid 
libraries that mimic the multivalency which characterizes many antibody-antigen 
interactions. In these experiments, pentanucleotide building blocks were chosen 
for the T4 DNA ligase-mediated polymerization, with the hypothesis that this length 
would be amenable to polymerization with longer peptide side chains.45 Using a 
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self-priming DNA template, pentanucleotide building blocks functionalized with ei-
ther a cationic or anionic octapeptide were efficiently polymerized, suggesting that 
this scaffold system could display a wide variety of peptide sequences. A mock in 
vitro selection experiment was performed using seven pentanucleotide building 
blocks that had been shown to undergo efficient ligation and an eighth building 
block having a hexahistidine tag. The resulting library was selected for binding to 
Co2+ magnetic beads, and an Xbal cleavage site was included in the template en-
coding the hexahistidine monomer in order to quantify enrichment (Figure 1.6). 
After completing one selection cycle, the hexahistidine-containing sequence was 
enriched nearly 200-fold, suggesting the potential of the T4 DNA-ligase-based 
polymerization to function for the in vitro selection of aptamers or DNAzymes. 
Figure 1.6. Selection of DNA sequences having displayed peptides. Peptide-bear-
ing fragments undergo templated ligation, and selected sequences can be PCR 
amplified and purified to regenerate single-stranded self-priming library. 
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Click-SELEX as a versatile method for incorporating 
functional groups 
The Mayer Group has recently presented a new approach termed ‘‘click-
SELEX” that enables the construction of nucleobase-modified aptamers utilizing 
the popular copper (I) azide-alkyne cycloaddition reaction.46 In this method, all thy-
midine nucleotides within the library are replaced with C5-ethynyl-2’-deoxyuridine 
(EdU), which introduces multiple alkyne functional groups into the sequences. The 
library is then further functionalized through reaction with an azide, which in the 
case of this initial demonstration was 3-(2-azidoethyl)indole. The resulting library 
was then subjected to in vitro selection to enrich aptamers having affinity for the 
protein cycle 3 GFP (C3-GFP). Sequences surviving each round of selection were 
amplified using PCR, with EdU triphosphate used in place of dTTP. This provided 
the enriched library having alkyne functional groups, which could again be reacted 
with the azide-containing molecule and utilized in the subsequent selection round 
(Figure 1.7). Notably, the bulk of the nucleobase modification is introduced after 
DNA amplification, which allows access to larger functional groups while avoiding 
the enzymatic incompatibility that often accompanies such modifications. After 15 
rounds of selection, the most abundant aptamer sequence was analyzed and 
found to have a dissociation constant of 18.4 nM. This aptamer also proved to have 
excellent specificity, displaying no observable binding to off-target proteins includ-
ing streptavidin, ERK2, and the closely related mE-GFP. A series of azides were 
utilized to assess the importance of the specific indole moiety used for the selection 
process. Aptamer variants functionalized with the alternative azides were not capa- 
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Figure 1.7. Selection of nucleobase-modified aptamers via click-SELEX. Post-
synthetic modification of the DNA library enables the incorporation of large func-
tional groups. These modifications are reverted to alkynes for PCR amplification. 
This enables the use of modifications that are not necessarily compatible with ex-
isting polymerases. 
ble of binding to the target protein even when the azide was structurally similar to 
the indole employed in the selections. This highlights the important role of the ap-
pended functional groups in target binding. The versatility with which side chains 
having a wide variety of sizes and chemical properties can be easily introduced 
using this method is anticipated to greatly accelerate the discovery of nucleic acid 
catalysts and affinity reagents having novel functions.  
Aptamer-based small-molecule biosensors 
This increased availability of aptamers to a variety of targets has empow-
ered research effort investigating their potential as alternatives to antibodies. Ap-
tamers provide many advantages such as increased thermal stability, time and 
cost efficient production, little batch-to-batch variation, and ease of modification to 
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suit a variety of applications.47 Because of these benefits, aptamers have been 
integrated into various applications such as environmental screening, therapeutics, 
drug delivery, and sensing.47 In particular, there has been growing interest in the 
utilization of aptamers as recognition elements in novel biosensor platforms.48 Bi-
osensors utilize a biological recognition event that can be translated into a meas-
urable signal (i.e., optical, electronic, electrochemical, fluorescent) using a trans-
ducer element.49 Fluorescence-based platforms have become widely popular, due 
to the wide variety of fluorophores available, ease of synthesis, and sensitivity.50 
Aptamers have been developed against molecules ranging from metal ions to 
whole cells,51 and thus together aptamer-based fluorescence assays hold great 
the potential to detect even the most difficult targets with high sensitivity.   
Small-molecules (< 900 g/mol) comprise varied classes of molecules includ-
ing toxins, biomarkers, drugs, and metabolites.52 Consequently, biosensors which 
respond to small molecules have many applications including triggered therapeutic 
response, environmental toxin detection, RNA imaging, medical diagnostics, and 
can provide insight into cellular pathways.53 There is great interest in utilizing ap-
tamers as recognition elements for small-molecule detection, however, there re-
main challenges in generating aptamers to small-molecule targets.54 Less than 25% 
of aptamers selected to date are to small-molecules likely due to the lack of func-
tional groups present in comparison to protein targets.52 Therefore, small-mole-
cules give lower probability of the pi-pi stacking, hydrogen bonding, and electro-
static interactions that govern aptamer-ligand binding.55 Additionally, there are 
technical challenges within the selection and characterization of small-molecule 
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aptamers.54 The small size of the target does not lead to a considerable mass 
change upon target binding, which complicates the partitioning of bound and un- 
bound sequences. This difficulty in distinguishing between the unbound and bound 
complex not only affects enrichment of high affinity aptamers but also postselection 
characterization. These obstacles are evident by the observed trend showing that 
ligand molecular weight is proportional to aptamer affinity (i.e., higher affinity for 
larger targets). Fortunately, in vitro evolution provides a customizable platform to 
strategically alter traditional selection methods in order to generate high affinity 
aptamers with enhanced properties. 
Favorable architectures for small- 
molecule detection  
 While traditional selection methods are well-established for the generation 
of aptamers, modifications are needed to function as signaling probes for biosens-
ing. Various aptamer sensor architectures have been developed to facilitate their 
integration as signaling molecules for fluorescence detection. The earliest example 
of this is molecular beacons, in which an aptamer is functionalized on both termini 
with either a fluorophore and quencher or a fluorescent donor-acceptor pair.56 De-
pending on which moieties are used, fluorescence signal can be turned on or off 
in the presence of target. While this method is simplistic, it requires a very specific 
secondary structure that is also sensitive to changes in environment which will alter 
spacing of the fluorophore and quencher.48 
 Split-aptamers are another type of sensor architecture uniquely suited for 
small-molecule detection. Split-aptamers consist of two strands that selectively as- 
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semble in the presence of their small-molecule target.57 Our lab has recently de-
scribed Split Aptamer Proximity Ligation (StAPL) showing that the termini of the 
split-aptamer fragments can be functionalized with reaction groups to promote 
DNA ligation (Figure 1.8a).58 Further research in our lab expanded this StAPL tech-
nology to enable successful implementation of a split-aptamer–based sandwich 
assay for cocaine detection (Figure 1.8b). Using the known split-aptamer for co-
caine, the capture strand was functionalized with an azide and the detection strand 
was modified with a cyclooctyne and biotin on opposite ends.59 The presence of 
the cocaine drives assembly of the split-aptamer which will place the reactive 
groups in close proximity, promoting cycloaddition and resulting in covalent ligation 
of the fragments.  A streptavidin-reporter enzyme conjugate can then bind the bi-
otin on the detection strand resulting in measurable colorimetric signal correspond-
ing to analyte concentration.  Despite this promise for biosensing assays, few ap-
tamers have been successfully engineered into split-aptamers, likely due to the 
difficulty in dividing most aptamer structures without disrupting the binding site.  
Aptamers are well-suited as recognition elements because the conforma-
tional change they undergo upon target binding can be exploited to generate signal 
output. Recent biosensor development has focused on the exploitation of this tar-
get-induced conformational changes in the form of structure-switching (SS) ap-
tamer sensors. This architecture is defined as a DNA/DNA duplex consisting of a 
fluorescently labeled aptamer and quencher modified, short complementary strand 
(CS) (Figure 1.9a). In the absence of target the duplex remains hybridized, how-
ever, in the presence of target the short CS will be displaced and fluorescence  
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Figure 1.8. Split aptamer technology. (a) Split aptamer ligation proximity ligation 
(StAPL) (b) Enzyme-linked small-molecule detection using StAPL. 
signal will be recovered. This architecture was first realized by Li and coworkers 
who created structure-switching sensors from existing aptamers for ATP and 
thrombin.60 However, because postselection engineering of aptamers into SS sen-
sors without insight into three-dimensional structure has proven difficult, there have 
been proposed methods for the direct selection of this architecture.  This was first 
exhibited by Nutiu and Li using a DNA library comprised of fixed motif flanked by 
two short random regions.61 As shown in Figure 1.9b, this fixed sequence at the 
center was designed to be complementary to the short CS which was immobilized 
on magnetic beads. After hybridization of the library to the CS-functionalized beads, 
sequences that successfully undergo a target-dependent structural change will be-
come dehybridized and released into solution and enriched. The resultant ap-
tamers to ATP and GTP could be directly converted into signaling aptamers, how-
ever, they produced only modest fluorescence enhancement in the presence of  
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Figure 1.9 SS aptamer-based biosensor design and selection. (a) SS-biosensor 
for small-molecule detection (b) Typical bead-based selection for generating SS-
biosensors as reported by Li and coworkers. 
target.61 This is likely due to the fact that small-molecule targets are challenging 
for the direct selection of SS biosensors as they lead to much smaller changes in 
aptamer structure in comparison to their protein counterparts. While this elegant 
approach provided a great advance in the direct selection of privileged sensor for-
mats, it highlights the limitations of bead-based selection methods. The rate of 
enrichment during SELEX is dictated by the resolution of separating binding from 
nonbinding sequences. Because affinity based methods (i.e., magnetic beads) re-
sult in the nonspecific retention of sequences, partitioning is low which hinders 
enrichment.62 The inability of traditional selection methods to guarantee the gener- 
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ation of aptamers possessing the desired SS architecture that produce sufficient 
fluorescence signal poses great technical challenges. Consequently, there remain 
great opportunities in the innovation of selection methods that can produce sen-
sors that are sensitive to small-molecule binding without laborious post-selection 
optimization.  
RNA aptamers to small-molecule fluorophores 
RNA is an incredibly fascinating and complex biopolymer that performs var-
ious cellular duties. The discovery of novel functions such as riboswitches, RNA-
protein complexes, and noncoding RNAs63 has shattered the preconceived idea 
that it operates solely as an intermediate in the transfer of genetic information. The 
ability to image RNA in cells has the potential to provide insight into their functions 
and elucidate the mechanisms of different pathologies. Nucleic acids have found 
utility as probes for the imaging of native mRNAs due to the high fidelity of Watson-
Crick base pairing. In the 1980s, fluorescence in situ hybridization (FISH) was in-
troduced, a method in which a fluorescently labeled nucleic acid complement is 
delivered into fixed (dead) cells to hybridize to the target RNA.64 While this method 
is able to achieve site-specific labeling, the use of fixed cells provides a stationary 
image of RNA. Therefore, methods to image RNA in live cells are in high demand 
as they allow the ability to resolve spatial and temporal information regarding lo-
calization patterns. The introduction of hybridization probes (FRET, molecular bea-
con, quenched autoligation) benefited from reduced background fluorescence, al-
lowing for visualization of endogenous transcripts in living cells (Figure 1.10 a-c).65 
Despite their simplicity, hybridization probes have not been widely implemented  
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Figure 1.10. Methods for mRNA imaging using nucleic acid probes: (a) hybridiza-
tion probes, (b) quenched autoligation probes, (c) molecular beacon, and (d) small-
molecule binding RNA aptamers. 
because delivery, stability, and subcellular distribution remain difficult obstacles to 
overcome.  
 In the search for novel RNA visualization techniques, researchers have re-
garded the molecular recognition capabilities of aptamers as a promising alterna-
tive. Several RNA aptamers have been reported that bind to small-molecule fluor-
ophores which benefit from high quantum yield and small size that is unlikely to 
perturb RNA behavior. Tsien and coworkers were the first to report an RNA ap-
tamer that could bind to a fluorogenic small-molecule, that is only fluorescent in 
the bound complex, in order to image b-lactamase expression in biological sam-
ples.66 Aptamer-based strategies were adapted to live-cell imaging with the devel-
opment of an RNA aptamer that bound a mimic of the GFP fluorophore, 3,5-
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difluoro-4-hydroxybenzylidine imidazolinone (DFHBI) (Figure 1.10d).1 Importantly, 
the use of an RNA aptamer allows the tag to be genetically encoded, obviating the 
need to exogenously introduce the probe. This aptamer called “spinach” due to the 
bright green fluorescence of the DFHBI upon binding, was successfully used to 
visualize ribosomal RNA in live mammalian cells.67 The spinach aptamer provides 
compelling evidence that nucleic acids are of great utility as labeling tags for RNA 
imaging, however, there are still drawbacks such as imaging sensitivity due to the 
noncovalent nature of the binding interaction. 
Dissertation overview 
Functional nucleic acids hold great promise for a variety of biosensing ap-
plications, and in vitro selection provides a powerful method to optimize nucleic 
acids for this purpose. This dissertation will explore novel SELEX methods that 
enable the generation of aptamers with enhanced functionality for small-molecule 
detection and imaging. We anticipate the aptamers generated by the techniques 
discussed herein will be optimized for the development of fluorescence assays. 
Collectively, these results suggest that the ability to push the boundaries of current 
selection technologies will be advantageous for the advancement of aptamer-
based biosensors. 
The discovery of naturally occurring ribozymes has shown that nucleic acids 
can function in more than base-pair and ligand-binding interactions. Their ability to 
catalyze a variety of chemical reactions has widened the scope of potential appli-
cations for catalytic RNA. In Chapter 2, we propose the use of ribozymes as novel 
tags for mRNA labeling and imaging. Using a novel IP-SELEX method, we were 
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able to generate self-alkylating ribozymes that are capable of catalyzing the cova-
lent attachment of a small-molecule fluorophore to itself. The use of a fluorophore 
binding antibody in the selection step provides a convenient method to recover 
sequences that successfully conjugate the label. We anticipate the covalent nature 
of this method will be advantageous over previous small-molecule binding ap-
tamers to allow for reduced background and prevent dissociation of the label and 
facilitate sensitive imaging of target RNA. We also explored the specificity and 
substrate scope of these ribozymes. Furthermore, we established that the ribo-
zyme can function when fused to an mRNA sequence, validating its promise for 
labeling in live cells. 
The evolution of enzymes that can transcribe and reverse transcribe XNA, 
has provided the ability to generate aptamers with novel attributes such as high 
nuclease stability. While such polymers have been evolved having affinity to pro-
tein targets, and even catalytic function, there exists no small-molecule binding 
XNA aptamer. We have developed a novel selection method to enable the creation 
of the first XNA aptamer capable of small-molecule recognition. We report the first 
aptamer selection using a fully XNA library, which obviates the need for post se-
lection alteration which may affect the integrity of the binding site. Using this 
method, we were able to generate TNA aptamers with high affinity to ochratoxin A, 
a food-borne mycotoxin. Further, we show that our best sequences can be struc-
turally minimized to enable chemical synthesis of our aptamers. We exhibit that 
these TNA aptamers are stable in the presence of nucleases and retain binding in 
conditions where DNA aptamers for the same target are completely degraded. 
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We recognize the promise of structure-switching biosensors in the detection 
of small molecules, but acknowledge the limitations of current bead-based tech-
nologies for acquiring the correct architecture. In Chapter 4, we introduce a novel 
method for the selection of SS biosensors to overcome the limitations of current 
SELEX capabilities. We propose a homogeneous PCR-based technique in which 
the library is designed to form a restriction enzyme cut site when hybridize to the 
CS to form the biosensor complex. Functional SS biosensors will undergo a con-
formation change upon target binding and displace the CS and nonfunctional se-
quences will remain hybridized. Upon introduction of the restriction enzyme, the 
non-functional sequences will be digested and only the functional SS-biosensors 
will be amplified to form full-length product. The use of the restriction enzyme pro-
vides a clever method of selectively amplifying functional sequences, as the non-
functional sequences will have their primer binding site removed during digest ion 
and will not form full-length product. Additionally, because the amplification step 
also serves simultaneously as the method of enriching functional sequences, this 
proposed selection is completely homogenous. This obviates the need for a solid 
support and anticipate this will overcomes the nonspecific elution associated with 
bead selections that negatively affects enrichment. We apply this method for the 
development of SS biosensors to coenzyme A to be used in the development of 
FP assays for histone acetyltransferases.  
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CHAPTER 2 
DEVELOPING AND EXPLORING THE SUBSTRATE SCOPE 
OF A SELF-ALKYLATING RIBOZYME 
FOR MRNA LABELING 
Introduction†
Localization and transport patterns for mRNA are key to many biological 
processes including cell growth and differentiation.1 Consequently, atypical RNA 
localization has been associated with the progression of several detrimental dis-
eases.2-4 Fragile X syndrome, which causes mental retardation and autism in 
males, is characterized by a mutation in the FMR1 gene. This gene codes for the 
RNA-binding protein FMRP, which is known to bind to ~4% of mRNA in the brain 
and is responsible for localization and translation of these RNAs in dendrites.5,6 
These processes are critical for proper synapse development,7 and thus dysregu-
lation of those mRNA can be deleterious. Therefore, there is a growing demand 
for techniques to visualize mRNA dynamics which could help elucidate these cel-
lular mechanisms and provide insight into the etiology and potential therapeutics 
†Adapted with permission from ACS Chemical Biology, Ashwani K. Sharma, 
Joshua J. Plant, Alexandra E. Rangel, Kirsten N. Meek, April J. Anamisis, Julie 
Hollien, and Jennifer M. Heemstra. Fluorescent RNA Labeling Using Self-Alkylat-
ing Ribozymes. Vol 9., Pages 1680-1684. Copyright 2014 American Chemical 
Society.	
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for such diseases. There are currently a number of sophisticated methods to label 
RNA, however, these methods suffer from limitations making them less suitable 
for cellular studies.  The predominant method, the MS2-GFP system, utilizes the 
MS2 bacteriophage coat protein (MCP) binding to a specific hairpin sequence (Fig-
ure 2.1a).8 Multiple copies of this sequence are encoded onto an mRNA of interest, 
which is co-expressed with a fusion of the MCP to a fluorescent protein such as 
GFP. The MCP-GFP fusion binds to the hairpin sequence with extremely high af-
finity, allowing visualization of the target mRNA.9 While effective, this method is 
characterized by drawbacks such as high background fluorescence and a bulky 
tag which is likely to perturb native RNA structure.10  
 
Figure 2.1. Methods for fluorescently labeling RNA using (a) RNA-binding proteins, 
(b) aptamer and fluorogenic small molecule, and (c) fluorescently self-alkylating 
ribozyme. 
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Recently, the small-molecule harnessing potential of aptamers, or short se-
quences of nucleic acids, have been seen as promising tools for improvements 
over previous labeling methods.11 Small molecule fluorophores have many bene-
fits for labeling including high quantum yield and small size less likely to perturb 
native RNA. Jaffrey and coworkers revolutionized the field in 2011 when they pre-
sented an aptamer for 4-hydroxybenzlidene imidazolinone, a GFP analogue, 
which could be attached to ribosomal RNA to enable visualization in live cells (Fig-
ure 2.1b).12 Perhaps the most novel aspect of this system is the use of a fluoro-
genic small molecule. Steric constraints in the aptamer bound state turns on fluo-
rescence, meaning that signal is only exhibited when the fluorophore is bound to 
the aptamer sequence.11 This work provided many advantages over the MCP-GFP 
system such as small cargo size and elimination of background fluorescence. 
However, the noncovalent interaction between aptamer and small molecule pre-
vents imaging sensitivity due to the possibility of the fluorophore dissociating from 
the aptamer. Nonetheless, this work provided huge improvements over previous 
labeling methods and established aptamers as a powerful tool to be implemented 
for such applications. 
The goal of the present research is to circumvent the limitations of previous 
RNA labeling methods through the development of a self-alkylating ribozyme that 
acts as the recognition element and provides a covalent linkage to the fluorophore 
(Figure 2.1c). Ribozymes, or catalytic RNAs, exist for a variety of functions and 
have shown promise for RNA labeling but have not been adapted for live cell ap-
plications.13,14 The covalent nature attachment not only offers additional stability of 
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the label, but also allows for excess fluorophore to be washed out of cells, conse-
quently reducing signal loss and background fluorescence. Importantly, our fluo-
rescently self-labeling ribozyme can be fused to an mRNA of interest to enable 
monitoring of localization and dynamics in living cells. Additionally, this covalent 
linkage also allows for critical advancement over previous methods in the way of 
potential applications.  
One such application is the ability to perform pulse-chase labeling experi-
ments. With this method, the target is labeled for a set amount of time and then 
excess fluorophore is removed which allows for time-resolved tracking of target 
biomolecules.15 We also hope to have the ability to identify proteins that bind to 
specific mRNA sequences using a transcript-specific RNA immunoprecipitiation 
(TRIP) process. Traditional IP methods rely on isolation using an antibody for the 
target protein and subsequent RT-PCR to identify bound RNA sequences.16 The 
lack of affinity reagents for RNA that function under IP conditions has made the 
identification of proteins that bind to specific RNA sequences a difficult task, and 
thus only limited examples of such experiments can be found in the literature.17 
Further, many of these methods rely on the affinity tag being attached to in vitro 
transcribed RNA with subsequent incubation in a cell lysate, which may alter RNA-
protein interactions.17 Our ribozyme will ensure that the fluorescein will bind to a 
specific RNA sequence in vivo, allowing for immunoprecipitiation of endogenous 
RNA-protein complexes.  In conjunction, these experiments will provide vital infor-
mation regarding transport mechanisms and localization patterns in cellular con-
text. Our self-alkylating ribozyme is the first RNA labeling probe to have all of the 
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characteristics necessary to successfully perform immunoprecipitiation and pulse-
chase labeling of specific RNA transcripts. 
In the present work we generate self-alkylating ribozymes capable of cova-
lently attaching fluorescein iodoacetamide (FIA) to itself using a novel systematic 
evolution of ligands by exponential enrichment (SELEX) method.18-21 Our motiva-
tion to utilize this chemistry originated from Wilson and Szostak’s report of an RNA 
capable of self-alkylation with biotin iodoacetamide (Figure 2.2a).22 Biotin is readily 
available in cells and has no potential for direct optical detection; hence we were 
motivated to use fluorescein because of its superior brightness (Figure 2.2b). We 
aimed to fully characterize our ribozymes by mapping the self-alkylation reaction 
site and exploring substrate specificity and scope with other fluorophores. We also 
determined the ability of our ribozyme to label when fused to an mRNA sequence- 
Figure 2.2. Chemical structure of (a) biotin iodoacetamide and (b) FIA. 
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a critical indicator of our system’s potential success for cellular labeling experi-
ments. Further, we show preliminary data supporting our ribozyme’s compatibility 
with conditions necessary for TRIP experiments. Altogether, this study demon-
strates the potential of our ribozymes as a promising tool for RNA imaging appli-
cations. 
Results and discussion 
IP-SELEX to generate self-alkylating ribozymes 
 In the process of selecting for our fluorescently self-alkylating ribozymes, 
we implemented an immunoprecipitation SELEX (IP-SELEX) process, in which “hit” 
sequences are pulled down using magnetic beads functionalized with an antibody 
for the fluorescein label (Figure 2.3a). This provides a convenient and highly se-
lective method for separating ribozymes from the over-whelming majority of inac-
tive sequences.23 Additionally, reverse transcription of the ribozymes is carried out 
on the beads, obviating the need for an elution step. As shown in Figure 2.3a, a 
starting DNA library was synthesized having a 116 nt random region (N116) 
flanked by two primer binding sites. We amplified this DNA by PCR using a forward 
primer containing the T7 promoter sequence and converted the products into the 
corresponding RNA library via T7 in vitro transcription. We then incubated the RNA 
library with 200 μM FIA (initial incubation time was 8 h but was reduced to 15 min 
over iterative SELEX cycles to drive the selection toward ribozymes having fast 
reaction rates). The labeling reaction was quenched with 2-mercaptoethanol, and 
the RNA was purified by ethanol precipitation. To isolate RNA sequences that had 








Figure 2.3. IP-SELEX to generate self-alkylating ribozymes. (a) SELEX Scheme-
a DNA library is PCR amplified and then transcribed into an RNA library. The RNA 
library is allowed to react with FIA, and then active sequences are pulled down 
using an antifluorescein antibody. (b) Denaturing PAGE showing fluorescein label-




prefunctionalized with an antifluorescein antibody. Unbound RNA was removed by 
washing, and bound RNAs were reverse transcribed and PCR amplified, resulting 
in a double-stranded DNA library that could be subjected to a subsequent round 
of selection.  
 We evaluated the overall reactivity of the RNA library after rounds 4, 7, 10, 
11, and 12. In these experiments, we incubated the library with 100 μM FIA for 15 
min, ethanol precipitated the RNA to remove excess FIA, and examined the prod-
ucts using denaturing PAGE followed by fluorescence imaging. The same quantity 
of RNA was loaded into each lane of the gel, such that the intensity of the fluores-
cein band is representative of reaction efficiency. Importantly, the denaturing con-
ditions of the gel disrupt any noncovalent RNA-fluorophore interactions, ensuring 
that fluorescence is observed only when the FIA is covalently tethered to the RNA 
sequence. Using this analysis, labeling efficiency appeared to plateau at round 12 
(Figure 2.3b). Thus, selection cycles were stopped, and the RNA library was am-
plified by reverse transcription-PCR, inserted into a TOPO cloning vector, and am-
plified in E. coli.  
 We sequenced 20 individual clones from the round 12 RNA library. This 
revealed four different types of ribozyme sequences, each represented by several 
highly related or identical clones. We then used PCR and in vitro transcription to 
generate representative ribozymes from each of the 4 groups and compared them 
using the denaturing PAGE assay described above (Figure 2.4a, lanes 1−4). All 
four sequences showed self-labeling activity, but sequences 1 and 5 appeared to 
be the most reactive. Importantly, control RNA sequences including the biotin self-  
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Figure 2.4. IP-SELEX results. (a) Denaturing PAGE showing fluorescein labeling 
of ribozyme sequences from SELEX using 10 µM and 100 µM FIA. Labeling yields 
determined by HPLC. (b) Pseudo-first-order rate constant vs. [FIA] for ribozymes 
1 and 5FR1. (c) Sequences for most reactive ribozymes. Sequences are displayed 
5’ to 3’ and primer binding sites are underlined.  
a b
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alkylating ribozyme and total cellular RNA do not show observable reaction with 
FIA (Figure 2.4a, lane 5), indicating that FIA reacts only with the selected ribozyme 
sequences and does not label RNA molecules nonspecifically.  
 The PAGE assay described above is useful for determining whether RNA 
sequences show self-labeling activity with FIA and can provide insight into the re-
active reactivity of these ribozyme sequences. However, this assay does not pro-
vide quantitative information regarding reaction yields. Thus, to quantify reaction 
yields, we turned to HPLC (Figure 2.4a). Both reacted and unreacted RNA elute 
together as a single peak, but the relative peak areas (A) for absorbance at 260 
nm (RNA) and 495 nm (fluorescein) can be used in conjunction with the molar 
absorptivity (ε) values for the RNA and fluorescein to calculate reaction yield ac-
cording to the equation: 
    %	𝑦𝑖𝑒𝑙𝑑 = 	 )*+,∗./01)/01∗.*+, ∗ 100                                     (1) 
Figure 2.4b shows the ligation yield for each of the ribozyme sequences after re-
action with either 10 μM or 100 μM FIA for 30 min. These data verified that se-
quences 1 and 5 show the fastest reaction kinetics, and thus we selected these 
two sequences for further analysis.  
Ribozyme minimization 
 To evaluate ribozymes 1 and 5, we first sought to determine whether the 
sequences could be truncated without impacting reactivity. Using denaturing 
PAGE and HPLC, we evaluated sequences having 18 nt removed from either the 
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5′ or 3′ terminus For ribozyme 1, shortening the sequence from either terminus to 
give 1F1R or 1FR1 resulted in a dramatic decrease in reactivity. For ribozyme 5, 
truncation at the 5′ terminus to give 5F1R also resulted in a dramatic decrease in 
reactivity. However, we were able to remove 18 nt from the 3′ terminus of ribozyme 
5 to give 5FR1 without impacting reactivity. Further truncation at the 3′ terminus to 
give 5FR2 resulted in a decrease in reactivity, and thus sequence 5FR1 was se-
lected for further study (sequences shown in Figure 2.4).  
Kinetics of self-labeling reaction 
To characterize the kinetics of the self-labeling reaction, we carried out la-
beling reactions under pseudo-first-order conditions using a large excess of FIA. 
Ribozymes 1 and 5FR1 were each reacted with FIA, then quenched, purified, and 
analyzed by HPLC as described above. For each concentration of FIA, we fit data 
from a series of time points to the integrated rate law [A] = [A]0 e−kt to give the 
pseudo-first-order rate constant (kobs) for that reaction (Figure 2.4b). We then cal-
culated the second order rate constant (k2) for each reaction was using the equa-
tion k2 = kobs /[FIA]. The values of k2 was averaged over the region that kobs vs [FIA] 
was linear (10−50 μM for 1 and 10−200 μM for 5FR1), providing k2 values of 100 
± 8 and 77 ± 12 M-1s-1 ribozymes 1 and 5FR1, respectively. Encouragingly, these 
rate constants are on par with those of other reactions that have been used suc-
cessfully for intracellular biomolecule labeling.24,25
We hypothesize that ribozymes 1 and 5FR1 bind to FIA, increasing effective 
molarity and thus promoting the self- labeling reaction. The corresponding reaction 
mechanism is represented by the equation below in which R is the ribozyme, F is  
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FIA, P is labeled between the unimolecular rate constant for conversion of ribo-
zyme-FIA complex into labeled product:26 
(2) 
Ribozyme specificity 
We first sought to evaluate the substrate specificity of our ribozyme se-
quences against other fluorophore iodoacetamides. We chose BODIPY FL iodoa-
cetamide (BFIA) for these studies, as the core structure of the molecule is much 
different and would allow us to determine if the ribozymes were specific for the 
xanthene core of the FIA (Figure 2.5a). Importantly, these molecules share similar 
spectral properties and can be compared directly on the same gel. We labeled 
sequences 1 and 5FR1 with 100 µM FIA/BFIA and then analyzed our results with 
a denaturing PAGE assay (Figure 2.5b). We include the ethidium bromide staining 
in our analysis to quantify all RNA present in the lane for reference. Approximate 
selectivity values were determined by comparing ratios of fluorescein/ethidium bro-
mide intensities for each sample. We were pleased to observe that our ribozymes 
are selective for FIA over BFIA with approximate selectivity of 160:1 and 280:1 for 
sequences 1 and 5FR1 respectively.   
Exploring the substrate scope 
For further exploration, we reacted both ribozyme sequences with tetra-
methylrhodamine iodoacetamide (TMRIA) and analyzed the results using PAGE 
analysis. Interestingly, we observed that not only do both ribozymes react with  
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Figure 2.5. Ribozyme specificity experiments. (a) Chemical Structures of FIA and 
BFIA (b) Denaturing PAGE gel shows labeling of ribozymes with 100 µM FIA and 
BFIA to explore substrate specificity. Ethidium bromide image of same gel after 
staining included to depict relative RNA loading. 
TMRIA but do so with higher efficiency than FIA. This is not surprising considering  
only positive selections were carried out in SELEX and TMRIA and FIA both have 
a similar xanthene based structures. With these results, we were curious to see if 
our ribozymes would show selectivity for the TMRIA over BODIPY 507 (Figure 
2.6a), similar to the experiment discussed above with FIA/BFIA. We determined 
that our ribozymes are selective for TMRIA over B507 with approximate selectivity 
of 500:1 and 102:1 for sequences 1 and 5FR1 respectively (Figure 2.6b). This 
result is encouraging as it shows that our ribozymes are specific for xanthene 
based fluorophores.  
 We were then interested in determining how the kinetics of the ribozyme 
labeling reactions differ between FIA and TMRIA. The kinetics of the self-alkylation  
reaction for both ribozymes with TMRIA were characterized by HPLC analysis as  




ribozyme      1           1         5FR1      5FR1







Figure 2.6. Ribozyme labeling with other xanthene iodoacetamides. (a) Chemical 
Structures of TMRIA and B507IA (b) Denaturing PAGE gel showing labeling of 
ribozymes with 100 µM TMRIA and B507IA to explore substrate scope. Ethidium 
bromide image of same gel after staining included to depict relative RNA loading. 
discussed for the initial characterization of the ribozyme reactivity with FIA. Ribo-
zymes 1 and 5FR1 were reacted with 100 µM TMRIA, and the reaction was 
quenched at different time points and analyzed by HPLC (Figure 2.7a). The relative 
peak areas at 260 nm (RNA) and 555 nm (TMRIA) were used to compute the 
reaction yield according to the equation used in the quantification of FIA labeling 
 yields mentioned previously. Since one concentration of TMRIA was used for this 
experiment, only the k2 could be determined, however, this still allows us to rela-
tively compare rates for both ribozymes with both iodoacetamides. With 100 µM 
TMRIA, ribozymes 1 and 5FR1 react 1.9 and 2.1-times faster compared to the FIA 
labeling reaction (Figure 2.7b). We hypothesize that promiscuity of our ribozyme 
will make our system easily integrated into a variety of imaging applications where 
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Figure 2.7. Ribozyme Labeling with xanthene-based fluorophores. (a) Labeling 
yields determined by HPLC for the reaction of ribozymes 1 and 5FR1 with 100 μM 
TMRIA. (b) Comparison of second order rate constants for labeling of ribozymes 
with FIA and TMRIA. 
our ribozymes will allow for color flexibility for time-resolved imaging, which re-
quires that each fluorophore be imaged individually (and emission spectra must 
not overlap). 
Mapping the reaction site 
Importantly, we aimed to locate the alkylation site for FIA on the ribozyme. 
We chose to use sequence 5FR1 for these experiments since it exhibits better 





















biotinylated on the 3’ terminus using a commercially available kit. Biotinylated ri-
bozyme was then subjected to hydrolysis in alkaline buffer according to the 
scheme in Figure 2.8. The alkaline hydrolysis fragments were then immobilized 
onto M-270 streptavidin magnetic beads and nonbound fragments were separated 
using a magnetic separation stand and discarded. The size of hydrolysis fragments 
eluted from the beads were analyzed using a denaturing PAGE and compared to 
the decade marker ladder to determine size. The gel was scanned for fluorescence 
and stained with SYBR Green II, which we chose because of its superior detection 
of RNA. The gel shows labeled 5FR1 sequences having 3’ terminus intact after 
hydrolysis. Only the full sequence shows fluorescein signal, and the next longest 
sequence observed using SYBR Green II has an approximate length of 100 nt 
(Figure 2.9). This indicates that the fluorescein reaction site is within the 40 nt 
closest to the 5’ terminus of the ribozyme. We hypothesize that our inability to re-
solve the specific reaction site is due to secondary structure present in the ribo-
zyme that prevents complete hydrolysis. We postulate that our ribozymes bind FIA, 
increasing effective molarity, and thus promotes the alkylation reaction. We pro-
pose that our ribozymes either bind FIA in a conformation that places the iodoa-
cetamide in close proximity to a nucleophilic group, or specific nucleotides in the 
ribozyme activate the electrophile for nucleophilic attack. 
Cellular labeling compatibility 
While the aforementioned experiment provides very useful information 
about the way our ribozymes function, we ultimately want to determine their com-
patibility with mRNA labeling experiments. To use our ribozymes for such studies,  
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Figure 2.8. Scheme of mapping protocol to determine reaction site for ribozyme 
5FR1. 
 
Figure 2.9. Denaturing PAGE showing fragments having 3’ terminus intact after 
hydrolysis. SYBR green II staining shown below to depict all RNA present in sam-
ple. 
100 nt
hydrolysis time (min)                

















it must be genetically encoded as a fusion to an mRNA of interest. In order for this 
to be plausible, we desired to verify that attaching the ribozyme to a much longer 
mRNA sequence would not impact reactivity. Ribozyme sequences were inserted 
into the 3’ untranslated region (UTR) of an RNA containing 432 nucleotides of the 
sequence coding for the mCherry fluorescent protein. This slightly truncated ver-
sion of the full mCherry sequence was used for better compatibility with PAGE 
analysis. Both 1 and 5FR1 were fused to the mRNA sequence to give fusions with 
single and multiple copies of the ribozymes, and were reacted with FIA and com-
pared to reactivity of an mCherry control sequence with no ribozyme attached. 
Unfortunately, our initial experiments showed no labeling of the fusions, even at 
very high concentrations of FIA and long incubation times. Our next steps were to 
determine what factors were impeding labeling and what necessary changes 
should be made to obtain fusion labeling.  We hypothesized that the mRNA, being 
a much larger sequence, might place itself in a conformation that prevents the self-
alkylating reaction when fused to the ribozyme. We reacted our ribozymes with FIA 
in the presence of increasing amounts of total cellular RNA (by weight) to investi-
gate if large amounts of RNA (i.e. the mCherry sequence) inhibit labeling (Figure 
2.10a). A progressive decrease in fluorescence intensity was observed with in-
creasing amount of total RNA, however, at 8X total RNA by weight labeling is still 
observed. We were encouraged that in the presence of such a large amount of 
RNA our ribozymes were still capable of reacting with FIA, however, labeling effi-
ciency is significantly diminished. We hypothesized that using a high concentration 







Figure 2.10. Ribozyme labeling in the presence of other RNAs. (a) Labeling of 
ribozymes in the presence of increasing total cellular RNA. (b) Effect of lowering 
RNA concentration (from 4 µM to 400 nM) on the ability of ribozymes to be labeled 
in the presence of other RNAs. 
to be so high that it cannot be effectively labeled.  Consequently, we performed an  
experiment in which we lowered the concentration of ribozyme 10-fold to 400 nM 
and attempted labeling in the presence of other RNAs (ribozymes, mCherry control 
sequence, and total cellular RNA). From these experiments, we observed no ob-
vious difference in fluorescence intensity of both ribozymes in the presence of 
other RNAs as seen in Figure 2.10b. We concluded that lowering our ribozyme 
concentration by a factor of ten would be more favorable for our fusion labeling 
experiments. In addition, we hypothesized that our SELEX buffer, containing a high 
concentration of lithium ions, was causing the mRNA to fold around the ribozyme, 
preventing effective labeling. As discussed previously, one application for our labe- 
sequence ladder     1       1       1        1        1                   ladder 5FR1  5FR1  5FR1  5FR1 5FR1




ribozyme 1                              - - - +         +         +         +        +
ribozyme 5FR1                        +         +        +         +         - - - +
total RNA (1:1 by weight)      - +         - - - +         - -





ling system is to be able to identify proteins that bind to mRNA sequences using 
our TRIP methodology. For our experiments, we will crosslink the RNA and pro-
teins in live cells, and fluorescein labeling will occur after cell lysis.  As a preliminary 
experiment, we wanted to determine if the conditions used to crosslink mRNAs to 
their protein binding partners would impact the reactivity of the ribozyme (Figure 
2.11). We incubated ribozyme 5FR1 with 1 and 0.1% formaldehyde, quenched 
with glycine and then attempted ribozyme labeling with FIA. We observed that the 
labeling of ribozyme incubated in buffer alone. These results suggest that our sys-
tem will be compatible with TRIP experiments and allow for successful identifica-
tion of protein which bind to specific RNA sequences. 
Labeling of mRNA fusions 
To test the ability of the ribozymes to function when fused to an RNA of 
interest, we inserted each ribozyme into the 3′ untranslated region (UTR) of an 
RNA containing 432 nucleotides of the coding sequence for the fluorescent protein 
exposed to formaldehyde was comparable to the labeling efficiency of ribozyme 
Figure 2.11. Labeling of ribozyme 5FR1 in crosslinking conditions 
glycine + +  - +




mCherry. As observed in Figure 2.12, we observe labeling for both of these ribo-
zyme-RNA fusions compared with the mCherry RNA alone as a control. We also 
sought to evaluate the ability of the ribozymes to undergo labeling in a complex 
biological sample, as the thiols present in proteins and glutathione may outcom-
pete the ribozyme for labeling with FIA. We were pleased to observe that labeling 
of the ribozymes proceeded in cell lysate with efficiencies similar to those observed 
in buffer. Including multiple copies of the ribozymes does not seem to have any 
benefit on the labeling yield.  
Conclusions 
We demonstrated that generation of self-alkylating ribozymes for small mol-
ecule targets is possible through a novel IP-SELEX method. Further, we show that 
our ribozyme is capable of fluorescently labeling with FIA through a covalent at-
tachment and are selective for FIA over other fluorophore iodoacetamides. Inter-
estingly, our ribozymes show faster reaction kinetics with TMRIA, which shares the 
same xanthene core structure as FIA. This promiscuity of substrate binding, while 
Figure 2.12. Labeling of ribozymes 1 and 5FR1 when inserted into the 3’ UTR of 
an RNA encoding a portion of the mCherry protein. Constructs included single and 
multiple copies of the ribozyme sequences. 
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surprising, suggests our ribozyme has multicolor imaging capabilities lending it as 
a versatile tool for potential imaging applications. Additional experiments were per-
formed to characterize the approximate location of the alkylation site and we de-
termined that the reactive site is within the first 40 nucleotides near the 5’ end of 
the ribozyme. Importantly, we show that both sequences show significant labeling 
when fused to an mRNA of interest, which is encouraging for success of our ribo-
zyme in vivo. Last, we show that labeling is still observed after RNA is subjected 
to crosslinking conditions, supporting the compatibility of our system for cellular 
labeling and applications such as TRIP. 
Materials and methods 
All DNA sequences were ordered from the University of Utah’s DNA and 
Peptide synthesis core facility. Enzymes were purchased from New England Bi-
olabs.  
Attachment of antifluorescein antibody to 
magnetic beads 
100 μL of M-280 streptavidin beads (Life Technologies) were washed three 
times with 200 μL of PBS. After each wash, the beads were separated from the 
supernatant using a magnetic separation stand (DynaMag-Spin, Life Technolo-
gies). The beads were suspended in 180 μL of PBS and 20 μL (20 μg) of biotinyl-
ated anti-fluorescein antibody (Abcam) was added. The suspension was agitated 
on a nutating mixer for 3 h at 37 °C, followed by overnight shaking at 4 °C to further 
ensure the maximum loading of biotinylated antibody onto the streptavidin beads. 
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The beads were washed three times with 200 μL of PBS, resuspended in 100 μL 
PBS and stored at 4 °C until further use.  
IP-SELEX 
 A dsDNA library (0.4−1 μg) was transcribed in a 20 μL reaction for 5 h at 
37 °C using an AmpliScribe T7-Flash transcription kit (Epicentre Biotechnologies), 
followed by DNase treatment for 1 h at 37 °C. The resulting RNA was precipitated 
using sodium acetate/ethanol. The precipitated RNA library was dissolved in 500 
μL of selection buffer (100 mM LiCl, 10 mM Na-HEPES, 5 mM MgCl2, pH 7.4) and 
coincubated with 200 μM 5-(iodoacetamido)fluorescein (Aldrich) at 37°C. The in-
cubation time was 8 h for the initial round of SELEX and was gradually shortened 
to 15 min over subsequent rounds of SELEX to increase the stringency of selection. 
The reaction was quenched by the addition of 100 mM β-mercaptoethanol, 5 mM 
EDTA, 0.3 M NaCl, and 50 μg of yeast tRNA (Ambion). After 15 min of quenching, 
the reaction was precipitated using sodium acetate/ethanol. 
 Twenty microliters of antibody-functionalized magnetic beads (suspended 
in PBS) was placed on a magnetic separation stand to enable removal of the su-
pernatant. The precipitated RNA was resuspended in 100 μL of PBS and added to 
the antibody functionalized magnetic beads. The mixture was incubated at RT for 
3 h with mild shaking. The unbound RNA was removed by washing the beads three 
times with 100 μL of wash buffer (1 M NaCl, 10 mM Na-HEPES, 5 mM EDTA, pH 
7.4) and then three times with 100 μL of water. The RNA-bound beads were sub-
jected to reverse transcription in a 25 μL reaction using 1 μL (200 units) of M-MLV 
reverse transcriptase (Life Technologies). The reaction was incubated at 37 °C for 
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1 h, then diluted into ThermoPol buffer (New England Biolabs), and subjected to 
34 rounds of PCR in a 500 μL reaction using the thermocycling protocol and pri-
mers described in the Supporting Information. The resulting dsDNA was precipi-
tated using sodium acetate/ethanol. The dsDNA was separated on a 2% agarose 
gel at 70 V for 45 min, and the desired band was cut from the gel and purified using 
a Zymoclean Gel DNA Recovery Kit (Zymo Research). The resulting dsDNA was 
used as a template for in vitro transcription for the next round of SELEX. After 12 
rounds of SELEX, the dsDNA was cloned into a TOPO vector using a TOPO TA 
cloning kit (Life Technologies) and amplified in E. coli. Plasmid DNA from 20 indi-
vidual colonies was recovered using a MiniPrep kit (Qiagen) and was sequenced 
at the University of Utah DNA sequencing core facility. 
Ribozyme labeling with fluorophore iodoacetamides 
 Reactions were typically carried out in a volume of 250 μL, in a solution 
containing 4 μM (unless specified otherwise) transcribed RNA and the specified 
concentration of IA (FIA, FBA, TMRIA, B507) in selection buffer or Dulbecco’s PBS. 
The reactions were incubated at 37°C for the specified time, then quenched by the 
addition of 100 mM b-mercaptoethanol, 5 mM EDTA, 0.3 M NaCl. After 15 min of 
shaking at room temperature, the reactions were precipitated using sodium ace-
tate/ethanol, stored at -80 °C for 12 h, then centrifuged at 17,000 × g for 15 min at 
room temperature. The resulting RNA pellet was washed with 2 x 200 μL of 70% 
ethanol, air-dried, and resuspended in 30 μl of RNAse free water. 
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PAGE analysis of labeling reactions 
 The RNA purified from each reaction was loaded onto a 6% polyacrylamide 
gel containing 8 M Urea. For reactions using the fusion constructs, samples were 
run on 3.5% polyacrylamide gels in order to resolve the larger sequences. The gels 
were run at 150 Volts for 1 h, and were analyzed on a Typhoon 9500 fluorescence 
laser scanner (Amersham Biosciences) using a 473 nm excitation laser/long pass 
blue (LPB) emission filter for fluorescein images and 532 nm excitation laser/long 
pass green (LPG) emission filter for rhodamine images. If required, the gels were 
stained with ethidium bromide or SYBR Green II solution for 15 min, then visual-
ized on a UV transilluminator or the Typhoon gel scanner. Some gels show slight 
laddering of the RNA which likely results from transcription errors. 
HPLC analysis of labeling reactions 
 Analytical high performance liquid chromatography (HPLC) was performed 
on an Agilent Technologies 1200 series HPLC system equipped with anion-ex-
change DNAPac PA 100 column (4 x 250 mm, ThermoScientific). The HPLC sol-
vents used were: 10% CH3CN in H2O (buffer A) and 10% CH3CN in 0.25 M Tris 
buffer, 0.375 M NaClO4, pH 8 (buffer B). The percentage of buffer B in buffer A 
was ramped from 20–40% over 20 min with a flow rate of 1.0 mL min-1. Elution 
from the HPLC column was monitored at both 260 nm and 495/555 nm (fluores-
cein/TMRIA). Peak areas for the RNA at each of these wavelengths were obtained 
by manual integration.  
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Hydrolysis to determine reaction site 
Ribozyme 5FR1 was reacted with FIA in a volume of 250 μL, in a solution 
containing 4 μM transcribed RNA and 100 μM FIA in PBS (Aldrich). The reaction 
was incubated at 37 °C for 30 min, then quenched by the addition of 100 mM β-
mercaptoethanol, 5 mM ETDA, 0.3 M NaCl. After 15 min of shaking at room tem-
perature, the reaction was precipitated using sodium acetate/ethanol and stored 
at -80 °C overnight.  This was then centrifuged at 17,000 x g for 30 min at 4 °C and 
the pellet was washed with 200 μL of 70% ethanol, air dried, and resuspended in 
20 μL of RNAse free water. Approximately 1-50 pmol of this RNA was end labeled 
on the 3’ terminus with biotin using the RNA 3’ Biotinylation Kit (ThermoScientific). 
The biotinylated RNA (0.1-3 μg) was mixed with 3 μg of yeast tRNA in a 
volume to not exceed 5 μL. 1X Alkaline Hydrolysis Buffer (50 mM Sodium Car-
bonate, 1mM EDTA, pH 9.2) was added to give a final volume of 15 μL. This mix-
ture was divided into three tubes labeled 1-3, and heated to 95 °C to hydrolyze 
RNA. The tubes were moved to ice after 30 s, 1 min, and 2 min, and then precipi-
tated with sodium acetate/ethanol for 1 hr at -80 °C. Tubes were centrifuged at 
17,000 x g for 15 min at 4 °C and the pellet was washed with 200 μL of 70% ethanol, 
air dried, and resuspended in 40 μL of 2X Binding and washing (B&W) buffer (10 
mM Tris, 1 mM EDTA, 2M NaCl). As a control, 40 μL B&W buffer was added to an 
equivalent amount (0.1-3 μg) biotinylated ribozyme (no hydrolysis) to serve as an 
additional size marker and to verify the success of biotin pull down on the magnetic 
beads. M-270 streptavidin beads (400 µL, Life Technologies) were washed three 
times with 400 µL of B&W buffer.  After each wash, the beads were separated from 
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the supernatant using a magnetic separation stand (DynaMag-Spin, Life Technol-
ogies). The beads were aliquoted into four tubes and resuspended in 40 µL of the 
solution containing resuspended fragments from the different hydrolysis times or 
the control biotinylated ribozyme in B&W buffer. The suspension was gently agi-
tated on a nutating mixer for 20 min at room temperature. The beads were washed 
three times with 40 µL of B&W buffer, and then resuspended in 40 µL of Elution 
Buffer (40 mM Tris, 10 mM EDTA, 3.5 M urea, 0.02% tween, pH 7.2). The solutions 
were heated to 90 °C for 5 min to break the biotin streptavidin bond. The beads 
were separated and the supernatant was removed immediately and placed at -20 
°C for further analysis. The RNA eluted from the beads was loaded onto an 8% 
(Tris/borate/EDTA) polyacrylamide gel with 8 M urea along with the Decade Marker 
(Life Technologies) ladder to determine the size of hydrolysis fragments. The gels 
were run at 200 V for 1 hr and imaged on a Typhoon 9500 fluorescence laser 
scanner (GE healthcare) using a 473 nm laser and long pass blue (LPB) emission 
filter. The gels were then stained with a 1X SYBR Green II (Life Technologies) 
solution for 20 min and then imaged using the 473 nm laser and a LPB emission 
filter.  
Ribozyme function in crosslinking conditions 
A total amount of 4 µM RNA was incubated with 1% or 0.1% formaldehyde 
for 10 min in PBS at room temp and quenched with 250 mM glycine. 400 nM RNA 
was subsequently labeled with 100 µM FIA in PBS, 30 min, 37°C. 
67	
Construction of ribozyme fusions to mRNA 
To assess the labeling ability of ribozymes in the context of a longer RNA 
sequence, we constructed vectors containing the coding sequence of the mCherry 
fluorescent protein with and without the R1 and 5FR1 ribozymes inserted into the 
vector 3’UTR. The parent plasmid was a vector designed to express green fluo-
rescent protein (GFP) in Drosophila cells (1), in which we replaced the GFP coding 
sequence with that of mCherry, using the Kpn1 and Xho1 restriction sites. We then 
further inserted the R1 ribozyme sequence between the Xho1 and BstB1 re-
strictions sites or the 5FR1 sequence between the Mlu1 and Sac1 sites; all of these 
sites are contained within the vector SV40 3’UTR. To synthesize RNA from these 
vectors for labeling tests, we used primers (forward: 
TTAATACGACTCACTATAGGGAGACCCCGAGGGCTTCAAGTGGGAGC, 
which also contains the T7 RNA polymerase binding site, and reverse: 
ACTGCATTCTAGTTGTGGT) to amplify regions containing 432 nucleotides of the 
mCherry coding sequence followed by the 3’UTR with and without the ribozyme 
sequences (total RNA lengths were therefore 659 nucleotides for the control, 800 
nucleotides for the R1-containing RNA and 724 nucleotides for the 5FR1-
containing RNA). These PCR products were subjected to in vitro transcription and 
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	CHAPTER 3 
 EVOLUTION OF ARTIFICIAL GENETIC POLYMERS  
CAPABLE OF SMALL-MOLECULE  
RECOGNITION 
Introduction 
 Life is controlled on a molecular level by the unparalleled ability of nucleic 
acids to store and process genetic information. This has inspired significant re-
search effort focused on understanding how nucleic acids evolve and function, and 
how these capabilities can be harnessed for applications in biotechnology.  In vitro 
evolution has proven to be a powerful tool for exploring these questions, and sim-
ultaneously provides a method for generating nucleic acid polymers having novel 
molecular recognition functionality. These polymers, known as aptamers, are sin-
gle stranded oligonucleotides that can be evolved through a process called SELEX 
(Systematic Evolution of Ligands by EXponential enrichment) to bind to a wide 
variety of target molecules with high affinity and specificity.1-3 Since their discovery, 
aptamers have shown promise in a variety of applications including therapeutics, 
affinity purification, and biosensing, where antibodies have long been considered 
the gold standard. Aptamers provide numerous advantages over antibodies includ-




can be chemically synthesized, enabling more cost-effective production and allow-
ing for the incorporation of a wide range of labels and nonnatural functional 
groups.4 However, aptamers comprised of native DNA and RNA retain some limi-
tations due to their instability in biological fluids and cellular environments.5 
Recently, there has been a growing interest in backbone-modified nucleic 
acids, or xeno nucleic acids (XNA), as these polymers are not readily recognized 
and degraded by nucleases, and thus are well-suited for in vivo applications.6,7 
Arguably, the most famous XNA aptamer to date is Macugen, a backbone-modified 
aptamer that binds vascular endothelial growth factor isoform VEGF165 to prevent 
the overgrowth of blood vessels associated with macular degeneration.8 In the de-
velopment of Macugen, aptamer sequences were evolved using native RNA, then 
the native nucleotides were systematically replaced with 2’-OMe or 2’-F nucleo-
tides to generate a biostable XNA aptamer that retained the necessary binding 
affinity to VEGF165. While this example supports the utility of XNA aptamers, the 
postselection modification strategy is expensive and time-consuming.  In contrast, 
the direct selection of aptamers from XNA libraries offers a more robust approach. 
Fortuitously, many XNAs are capable of Watson-Crick base pairing with DNA and 
RNA, which has provided encouragement for their use as alternative genetic sys-
tems.9 Recent efforts in this field have generated replication technologies that per-
mit information transfer between DNA and different XNAs, establishing the capac-
ity for in vitro evolution using these artificial genetic systems.10 While the direct 
selection of XNA aptamers holds significant promise for generating biopolymers 
having novel functions, these artificial genetic systems can present challenges for 
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in vitro selection experiments. An initial challenge is the limited availability of the 
building blocks and polymerases needed to create XNA polymers. For many 
nonnatural nucleic acids, the phosphoramidites and triphosphates needed for solid 
phase and enzymatic synthesis, respectively, are neither commercially available 
nor easily synthesized.  Additionally, while recent advances in enzyme engineering 
have provided polymerases capable of XNA transcription and reverse transcrip-
tion, they are often characterized by lower fidelity and processivity.11 Consequently, 
transcription efficiency is often reduced, which can lead to undersampling of library 
diversity and introduce sequence bias that negatively impacts the efficacy of the 
selection.12  Additionally, the difficulty of generating and utilizing XNA primers has 
limited transcription to techniques where the polymer is extended from a DNA pri-
mer to yield a DNA-XNA chimera. While aptamer selections using these chimeric 
libraries have been successful, the DNA portion is often involved in target binding 
and cannot be completely removed or converted to XNA postselection. Under bio-
logical conditions, this vital region of the aptamer may then be degraded, compro-
mising the binding affinity of the aptamer. To date, direct selection using chimeric 
DNA-XNA libraries has provided hexitol nucleic acid (HNA) aptamers to hen-egg 
lysozyme and HIV trans-activating response RNA element,11 a (3’,2’)-α-ι-threose 
nucleic acid (TNA) aptamer to human thrombin,13 a 2’-deoxy-2’-fluoroarabinonu-
cleotide (FANA) aptamer to HIV-1 reverse transcriptase,14 and a 2’-fluoro-modified 
aptamer for human neutrophil elastase (HNE).15 
These examples demonstrate that despite the challenges associated with 
in vitro selection using XNA, aptamers comprising a variety of backbone structures 
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can be generated for protein targets.  However, successful selection of an XNA 
aptamer to a small-molecule target has yet to be reported. It is widely accepted 
that small molecules are more difficult targets for aptamer selection compared to 
proteins. In general, small molecules present significantly less surface area and 
fewer functional groups for the aptamer to interact with to gain favorable binding 
interactions.16 These factors also complicate the partitioning of bound from un-
bound sequences, as selection methods typically rely on immobilization of the tar-
get molecule. This inherently compromises one functional group on the target, 
which carries a significantly greater risk in the case of small-molecule targets.17 
Furthermore, the relatively small change in size between free XNAs and those 
bound to the small-molecule target presents complications in the screening and 
characterization of putative aptamer sequences. Given these challenges, it is not 
surprising that only ~25% of all reported selection experiments are for small-mol-
ecule targets.17 However, many small molecules including toxins and biomarkers 
play key roles in biology and the environment, therefore developing receptors that 
can sensitively and selectively detect these targets is of high utility.  
Given the exciting capabilities provided by XNA in the context of protein 
recognition, we sought to extend these by selecting the first XNA aptamer to a 
small-molecule target. As our target molecule, we chose ochratoxin A (OTA), a 
food-contaminating mycotoxin which causes nephrotoxic effects when consumed 
(Figure 3.1a).18 OTA has a negative immunogenic response, which makes it an 
interesting target for aptamer development, as antibodies are difficult to generate. 





Figure 3.1. Relevant chemical structures of (a) ochratoxin A (OTA) and (b) TNA 
and DNA polymers. TNA has a five-atom backbone perodicity and phosphodiester 
linkages at the 3’ and 2’ positions of the furanose ring 
on and functional validation of our newly generated XNA aptamers.  We anticipated 
that TNA would be well-suited for in vitro evolution because of the availability of 
enzymes that support efficient in vitro transcription and reverse transcription, as 
well as its superb stability in the presence of nucleases (Figure 3.1b).19,20 Given 
the increased difficulty of generating aptamers to small-molecule targets, we intro-
duced new capabilities in XNA SELEX aimed at increasing enrichment efficiency 
and ensuring binding of the free target molecule. Central among these was the use 
of a TNA primer to give a fully nonnative library (Figure 3.2). Additionally, the TNA  
primer allows us to digest DNA contaminants that may hinder the enrichment of 
high affinity TNA aptamers. Small-molecule selections typically take 10 ± 6 round 
















































Figure 3.2. TNA SELEX to generate OTA-binding aptamers. The initial ssDNA 
library is amplified using a forward primer modified with a PEG spacer and polyT 
tail to enable separation and recovery by denaturing PAGE. The PEGylated DNA 
template is then annealed to the FAM-labeled TNA primer and extended using 
KOD RI polymerase to generate the TNA library for each selection round. The TNA 
library is incubated with OTA-functionalized magnetic beads, and bound se-
quences recovered by either heat (rounds 1-4) or ligand elution (rounds 5-9). 
These sequences are then treated with DNase I to digest any remaining DNA tem-
plate. The TNA is then reverse transcribed back into DNA using Bst DNA polymer-










































DNase digestion will improve the efficiency of our selection. Using our improved 
SELEX protocol, we generated seven sequences having affinity for OTA.  Analysis 
using microscale thermophoresis (MST) revealed that five of these sequences 
have KD values in the nM range, with the best being 92 ± 2 nM. Importantly, the 
use of MST to quantify the binding affinity of our aptamer sequences confirms that 
despite the use of immobilized target during the selection experiments, our ap-
tamers are capable of binding to the free target in solution. Using secondary struc-
ture predictions, we were able to minimize two of our aptamer sequences to a 
functional core <35 nt, a length that enables chemical synthesis using phospho-
ramidite monomers available in our lab. Aptamer A04T.2, our shortest sequence 
at 31 nt, was found to have a KD of 71 ± 8 nM.  This represents tighter binding than 
even the best DNA aptamer to OTA, and is the first example of a TNA aptamer to 
be validated by chemical synthesis. Using this truncated aptamer sequence, we 
demonstrate the impressive resistance of TNA to degradation by DNase I, human 
liver microsomes, and human blood serum. Furthermore, we highlight the selec-
tivity of our TNA aptamer in that it retains binding affinity for OTA in the presence 
of 50% human serum.  Together, these experiments demonstrate that XNA ap-
tamers having high affinity and selectivity can be generated for small-molecule tar-





Materials and methods 
Oligonucleotides synthesis 
TNA triphosphates used for primer extension reactions were synthesized as 
described previously.22,23 TNA phosphoramidites were synthesized by unpublished 
methods developed in our lab for solid phase synthesis of TNA polymers. All DNA 
and chemically synthesizable TNA sequences were purchased from the University 
of Utah DNA/Peptide Synthesis Core Facility. All oligonucleotides were purified by 
denaturing PAGE and the desired band was excised and incubated in crush and 
soak buffer (300 mM ammonium acetate, 1 mM EDTA, pH 8.0) at 40°C overnight. 
Samples were separated from gel pieces and buffer exchanged into water using 
Amicon Ultra-0.5 Centrifugal Unit with Ultracel 10 membrane (EMD Millipore). 
Attachment of ochratoxin A to magnetic beads 
300 μg of OTA (Enzo Life Sciences) was suspended in 500 μl of 0.1 M MES 
buffer, pH 5. After equilibration to room temperature, 0.4 mg EDC and 1.1 mg sulfo-
NHS were added to the OTAA solution and allowed to react for 15 min. 1.2 μl of 2-
mercaptoethanol was added to the reaction to quench the remaining EDC. 500 μl 
of M-270 amine beads (Life Technologies) were washed three times with 1 mL 1x 
PBS. After each wash, the beads were separated from the supernatant using a 
magnetic separation stand (DynaMag-Spin, Life Technologies). The beads were 
re-suspended in 500 μl 1x PBS and added to the solution of OTA. After allowing 
the reaction to proceed for 1 h, hydroxylamine was added to a final concentration 
of 10 mM to quench the remaining NHS ester. The functionalized beads were 
washed three times with 1 mL binding buffer and re-suspended in 500 μL binding 
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buffer for storage at 4°C. Successful attachment of OTA was validated by monitor-
ing fluorescence intensity (lex = 380 nm, lem = 444 nm). 
PCR amplification of ssDNA library 
A single stranded DNA library having the sequence 5’-GCGCAT-
ACCAGCTTATTCAATT-N50-AGATAGTAAGTGCAATCTCGGC-3’ (20 pmol) was 
amplified in 50 μL PCR reactions containing 0.2 μM template, 0.2 μM each primers, 
200 μM dNTPs, and 2.5 U Taq DNA polymerase in 1x Thermopol buffer (20 mM 
Tris-HCl, 10 mM (NH4)2SO4, 10 mM KCl. 2 mM MgSO4, 0.1% Triton X-100, pH 8.8, 
New England Biolabs). The forward primer had the sequence 5’- 
TTTTTTTTTTTTTTTTTTTT/Sp9/GCGCATACCAGCTTATTCAATT-3’ and the re-
verse primer had the sequence 5¢-/FAM/GCCGAGATTGCACTTACTATCT-3¢. PCR 
was carried using a program with an initial denaturation at 95°C  for 3 min, 20 
cycles of (95°C for 30 s, 54 °C for 30 s, and 72 oC for 20 s), and a final extension 
72 oC for 2 min. The amplified double stranded DNA was purified using a PCR 
cleanup column (Qiagen) and the PEG-functionalized strand was separated from 
the FAM labeled strand on a denaturing 10% polyacrylamide gel. The gel was 
stained with ethidium bromide and the desired band was excised and incubated in 
crush and soak at 40°C overnight. Samples were recovered using size-exclusion 
centrifugal units as described previously.  
Transcription of TNA library 
The TNA library was generated by primer extension using 75 pmol of puri-
fied PEGylated ssDNA library. Primer extension reactions were performed in 10 μL 
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volumes containing 100 µM tNTPs with 500 nM primer-template complex. The 
FAM labeled TNA primer having sequence 3¢-/FAM/GCCGAGATTGCACTTACTA-
TCT-2¢ was annealed to the PEGylated ssDNA in 1x Thermopol buffer by heating 
to 95 °C for 5 min, cooling to 4°C for 10 min, and incubating at 50°C until addition 
of the enzyme. KOD RI TNA polymerase was pretreated with MnCl2 (1 mM) in a 
1:1 v:v ratio and added to the mixture. tNTPs were added last at a final concentra-
tion of 100 μM, and the reactions were incubated at 50 °C for 10 h. Primer exten-
sion reactions were quenched using TNA stop buffer (50% (w/v) urea, 10 mM 
EDTA) and denatured at 95°C for 5 min. Reactions were pooled and purified on a 
denaturing 10% polyacrylamide gel as described above. 
TNA SELEX 
The purified TNA library (~1013 sequences) was folded in 1x selection buffer 
(100 mM NaCl, 2 mM MgCl2, 5 mM KCl, 1 mM CaCl2, 0.02% Tween 20, 20 mM 
Tris-HCl, pH 7.6) in a total volume of 500 μL by heating to 95 °C for 5 min, cooling 
at 4 °C for 10 min, and a final incubation at 25 °C for 10 min. 70 μL (1.8 x108) of 
OTA functionalized beads were washed three times with selection buffer and then 
re-suspended in the 500 μL of folded TNA library. After incubation for 1 h at 25 °C, 
the unbound sequences were removed by washing three times with 100 μL binding 
buffer, using the magnetic stand to separate the supernatant from the beads. The 
beads were re-suspended in 100 μL binding buffer and the bound sequences were 
recovered by elution with heat at 95 °C for 5 min. The heat elution step was re-
peated twice. Starting at round 5, bound sequences were recovered by target elu-




500 μL of OTA (100 μM) for 1 h. After incubation, the supernatant containing the 
bound sequences was separated from the beads and concentrated using a 10 kDa 
spin filter. The amount of recovered TNA was quantified by comparison to a cali-
bration curve created using a FAM-labeled TNA standard of the same size. The 
standard and SELEX output were analyzed for fluorescence intensity using a Bio-
Tek Synergy 2 multimode plate reader.  
DNase digestion to remove DNA contaminants 
  The recovered TNA was divided into 10 μL portions and 1.5 U DNase I 
(New England Biolabs) was added to each aliquot.  The solutions were incubated 
for 45 min at 37°C. The DNase was denatured for 10 min at 75°C and the TNA 
solutions left on ice until further use. 
TNA Reverse transcription and regeneration of  
ssDNA library 
 Reverse transcription reactions were performed in a 20 μL reaction volume. 
7.4 μL of the TNA/DNase mixture was combined with dNTPs (500 μM) and MgCl2 
(3 mM) in 1x Thermopol buffer. The recovered TNA was annealed with 5 pmol of 
unmodified forward primer in 1x Thermopol buffer as previously described.  1.6 U 
of Bst DNA polymerase I large fragment (New England Biolabs) was added to the 
primer-template complex and the reaction incubated at 55 °C for 3.5 h. The RT 
reactions were divided into 5 μL aliquots and PCR amplified as previously de-
scribed for the DNA library using unmodified versions of the forward and reverse 




using MinElute PCR clean up columns and reamplified using the PEG-forward and 
FAM-reverse PCR primers to enable strand separation. The recovered PEG-func-
tionalized DNA template was then used to initiate transcription of the TNA library 
for the subsequent round of selection.  
Initial screening of putative aptamer sequences 
 After 9 rounds of selection, cDNA from rounds 7, 8, and 9 were amplified in 
separate PCR reactions using unmodified primers and cloned into a pCR™4-
TOPO® TA vector using a TOPO TA cloning kit for sequencing (Life Technologies). 
The vector was amplified in E. coli and plasmid DNA was recovered from 25 colo-
nies per selection round using a Miniprep Kit (Quiagen).  These DNA plasmids 
were sequenced at the University of Utah DNA sequencing core facility. Se-
quences were aligned using Multalin and secondary structure analysis was per-
formed using the DNA folding form in Mfold (Figure 3.3).24 DNA templates corre-
sponding to the 10 potential TNA aptamer sequences were ordered having a PEG-
T20 modification, enabling them to be directly used for TNA synthesis. The 
PEGylated templates were annealed to the FAM-labeled TNA reverse primer as 
previously described to generate TNA for each potential aptamer.  
MST analysis of binding interactions with OTA 
 MST experiments were performed by 2bind GmbH. Briefly, a serial dilution 
of OTA in the appropriate binding buffer was carried out to provide solutions having 
a range of concentrations between 1.832 nM and 60 μM. 5 μL of each solution was 





Figure 3.3. Secondary structure analysis of putative aptamer sequences using 
Mfold. For these predictions, the folding temperature was set to 25 °C and the ionic 
conditions were [Na+]= 100 mM and [Mg2+]= 2 mM. 
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ration of 10 nM. The final concentrations of OTA in each capillary ranged from 916 
pM to 30 μM. Each sample was analyzed on a Monolith NT.115 Pico at 25 °C, with 
40% LED power and 80% laser power. Data were fitted using Origin Lab analysis 
software to determine the aptamer KD values. To calculate the fraction bound (FB), 
raw fluorescence data acquired for each concentration point during the MST ex-
periments were averaged (avg) for technical repeats and plotted versus concen-
tration. A dose response fit was performed for each data set and the maxi-
mum(complexed) and minimum (free) values for each curve were recorded. These 
values were then used to determine the normalized fraction bound for each ap-
tamer using the equation FB=(avg–free)/(complexed–free). A Hill fit can then be 
performed to determine KD. 
Sequence minimization and evaluation 
 To qualitatively assess binding of enzymatically-synthesized truncated se-
quences A04T and B29T, OTA functionalized magnetic beads were washed three 
times with binding buffer and separated into aliquots of 20 μL (2 x 107) beads. 4 
pmol of each aptamer sequence was folded in binding buffer and then added to an 
aliquot of beads and incubated for 1 h at 25 °C. Unbound sequences were re-
moved using three washes with binding buffer and then the bound fraction was 
eluted into 100 μL buffer by heating to 95 °C for 10 min. Fluorescence was ana-
lyzed using a plate reader as described above to determine the percentage of ap-
tamer bound to the beads. Binding affinities for truncated aptamer sequences were 




TNA stability assay 
 FAM-labelled DNA aptamer A08 and TNA aptamer A04T.2 were prepared 
in three nuclease challenge conditions: 1.5 U DNase I (RNase-free, New England 
Biolabs) in 1x DNase I reaction buffer (10 mM Tris-HCl, 2.5 mM MgCl2, 0.5 mM 
CaCl2, pH 7.6), 50% v/v human blood serum (normal pool, Fisher BioReagents) in 
1x Dulbecco’s PBS, 0.5 mg/mL pooled human liver microsomes (XenoTech) in 1x 
selection buffer. TNA and DNA aptamer (4 pmol) were each folded in the respec-
tive buffer for each condition and DNase I, human blood serum, and human liver 
microsomes were added to the desired concentration. These samples were then 
incubated at 37 °C for three days, separated on a denaturing 10% polyacrylamide 
gel, and analyzed using a GE Typhoon laser gel scanner. TNA and DNA aptamers 
folded in selection buffer were used for comparison in these experiments. The 
samples were also assessed for their ability to retain OTA binding using a bead-
binding assay. Samples were prepared as described above and incubated with an 
aliquot of 20 μL (2 x 107) OTA-functionalized beads for 30 min at 25 °C. Bound 
sequences were recovered after three washes using heat elution and quantified 
by fluorescence. For the MST experiments, Cy5-labeled DNA aptamer A08 and 
TNA aptamer A04T.2 were folded in 1x Dulbecco’s PBS at a final concentration of 
100 nM. An equal volume of human blood serum was added and the mixture was 
incubated at 37 °C for either 3 or 7 d. Binding affinities were measured for the 




Results and discussion 
Transcription of a fully XNA library using a TNA primer 
Typical XNA SELEX experiments utilize a DNA primer, upon which an XNA 
library is synthesized using enzyme-mediated primer extension. This can create 
challenges postselection, as removing the primer sequence or converting it to XNA 
may lead to a decrease in binding affinity of the aptamer.  Additionally, because 
the engineered polymerases used to transcribe and reverse transcribe XNA still 
have a strong bias toward DNA, small amounts of DNA contamination can under-
mine the enrichment of aptamer sequences.  We anticipated that this would be 
especially problematic in the selection of aptamers for small-molecule targets, but 
recognized that if we could use a TNA primer to provide fully TNA library, then 
DNase digestion could be employed to eliminate unwanted DNA contamination 
during the selection rounds. The gel image in Figure 3.4 shows that in the absence 
of DNase, residual DNA template amplifies efficiently, evident by the comparable 
fluorescent band in the positive and negative reactions. We know that any product 
being amplified in the negative reaction is due to DNA contamination as TNA can-
not be direct amplified by PCR. With the use of DNase we see selective amplifica-
tion of TNA that has been reverse transcribed which is supported by the higher 
fluorescence signal in comparison to the control. We observe that excess DNase 
seems to slightly inhibit PCR and concluded we would use1.5 U DNase as it pro-
vided the largest selectivity between the positive and negative reactions  
Thus, before beginning our aptamer selection, we performed initial exper-
ments to determine whether TNA transcription would be possible using a TNA pri 
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Figure 3.4. Optimization of DNase I digestion. 200 pmol of TNA library was incu-
bated with designated amount of DNase I for 45 min at 37 °C and heat inactivated 
at 75 °C for 10 min.  Each sample was then divided in half and used in a positive 
(with Bst DNA polymerase) or negative (no polymerase) reverse transcription re-
action). 
mer. Given the significant structural differences between TNA and DNA/RNA, a 
key challenge in TNA SELEX is the availability of polymerases capable of tran-
scribing DNA into TNA and reverse transcribing TNA into DNA. The Chaput lab has 
recently made a number of exciting advances in this field, and while completely 
unbiased libraries still remain somewhat problematic due to G:G mispairing during 
TNA transcription, libraries having all four letters can now be transcribed effi-
ciently.25-27 In exploring transcription from a TNA primer, we anticipated that a li-
brary having an N50 random region composed of 38.5% each of A and T and 11.5% 
each of C and G would allow for sufficient diversity and secondary structural ele-
ments, while also permitting efficient and faithful transcription. To evaluate the fi-
delity of transcribing this four-letter library, we first needed to optimize conditions 
for the primer extension reaction (Figure 3.5). An initial transcription reaction using 
our SELEX library and TNA primer revealed that the original incubation tempera-
ture for the primer extension reaction (55 °C) yielded no full-length product. We 
performed a temperature screen, and found that an incubation temperature of 50 
°C and time of 10 h was optimal for reactions using the TNA primer. In Figure 3.6  
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Figure 3.5 Temperature screen of TNA transcription using a TNA primer. The TNA 
primer was annealed to the SELEX library and incubated in a primer extension 
reaction for 10 h at the designated temperatures. No product was observed at 
temperatures above 55°C. 
Figure 3.6. Comparison of TNA transcription efficiency of our SELEX library using 
a DNA versus TNA primer. 500 nM primer and 11.5% G,C and 38.5% A,T library 
were annealed and TNA was transcribed by primer extension at 50 °C for 10 h. 
The transcription efficiency using the TNA primer (19%)  was approximately half 








we observe the yield of this reaction is slightly less than what we observe using a 
DNA primer, but we hypothesized that this would not be problematic if the se-
quences that were being transcribed had the expected nucleotide content, indicat-
ing that transcription from the TNA primer does not introduce unwanted sequence 
bias. To determine nucleotide distribution and evaluate the fidelity of the transcrip-
tion of our library, TNA from a scaled up primer extension reaction was recovered 
and reverse transcribed into the corresponding DNA library. The DNA library was 
amplified using the appropriate primers and inserted into a TOPO vector, cloned 
into E. coli, and DNA from 20 clones was submitted for Sanger sequencing. Anal-
ysis of the library sequences revealed that the average amount of each nucleotide 
in the random region was 32.3% A, 10.3% G, 39.8% T, and 17.2% C (Figure 3.7). 
While these percentages differ slightly from the starting composition of our library, 
the retention of all four nucleobases suggests that any sequence bias is limited, 
and given the transcription efficiency achieved, we concluded that primer exten-
sion using the TNA primer under our optimized conditions would be suitable for 
use in our selection experiments. 
TNA SELEX for small-molecule targets 
To initiate selection experiments, our ssDNA library was amplified using 
modified PCR primers (Figure 3.2), which allow strand separation by gel electro-
phoresis. The PEGylated ssDNA library was recovered and annealed to a FAM-
labeled TNA primer, then extended using KOD RI polymerase and tNTPs to gen-
erate the TNA library.  We began our selections with approximately 15 pmol (~1013 




Clone 1 (31,6,54,10) 
ATTTAATGAAACTAATCTTTAACTTATGCTAATTGTATTCATTTTTATTT 
Clone 2 (25,12,52,12) 
AATCATTTTTAGAAATTCTTTTATTTCTATGGATTGACCTTTGTAACGTT 
Clone 3 (25,0,35,40) 
ACCTCATACAACTTACCCATAATCACCCACTCCTCTTACTACCCTTCTTT 
Clone 4 (33,0,38,29) 
ATTAATACACTAACACACCTTATAAACCTCATTCTCTTTCCTCTTACAT 
Clone 5 (36,12,42,10) 
ATATAACTATATTAGATAACTGCTTATATAGGCCTATTGATAATATTTTG 
Clone 6 (28,10,44,18) 
AGATATTACTCTTCATCAGGCTTCCCTATTATTATTATTCGTAAGATATT 
Clone 7 (42,0,48,10) 
ATATTAACAATCTTTATTTAAATTATTAATTTTTAAAATACCAATTTACT 
Clone 8 (32,12,44,12) 
TTACTTCTTGTACCATTATAACCGGTAATGGTTTTAGATATATATTAATA 
Clone 9 (38,10,40,12) 
AGACGATTACTAAAAATTACATATATCTTATAAGCTTGGATATTTTTACT 
Clone 10 (33,0,35,31) 
ATTAATACACTAACACACCTTATAAACCTCATTCTCTTCCTCTTACAT 
Clone 11 (35,8,35,22) 
CCTATATGCCTTGAATAATCATTTATTAAATTCGAGCCTCAATTACCAA 
Clone 12 (34,18,42,6) 
ACTGATTATATATAATTAATTGTCTGGTGAGATTGAATATCAGATTGATT 
Clone 13 (32,18,36,14) 
AGCAGATTTTAAAAACTTCGTACTATGTATTGACCGTTAATTTAATGGGC  
Clone 14 (35,14,41,10) 
ATAGATTTTTGGAATGCTATTCATGTAATAATCAACAGTCTAATAGTTT 
Clone 15 (22,12,56,10) 
AATTCGTTTTTAGTATTTTTACTTAATGGCTTCTGGTAATTTTTACTATT 
Clone 16 (38,8,40,14) 
ATTTTATCCAAAAATATTTTTCACTGTACTATATATACAAAAGGATGTCT 
Clone 17 (48,12,30,10) 
ACTAGAAACTAAAGGATCATACTAAAATATTTTATTAGAAACGTATATAG 
Clone 18 (21,0,40,38) 
ACCCTCCACCTATCAACCACAACTCATTCTCCCTTCTTTTTATTTTCTAC 
Clone 19 (31,8,43,18) 
ATCTCATTAACTTCTTATAATTATTTCGAGTCATACTACTATTTACAGG 
Clone 20 (28,10,44,18) 
TTTTTTAAGAAGGGATATATTCATCACCCTCAATACTCAATTGTTTCTTT 
Figure 3.7. Sequence analysis of SELEX library transcription. TNA generated from 
a scaled up primer extension of the 11.5% G,C and 38.5% A,T DNA library was 
reverse transcribed and the cDNA was inserted into a vector using a TOPO TA 
cloning kit for sequencing. Sanger sequencing was used to determine the nucleo-
tide composition of 20 unique clones. Numbers in parentheses indicate the per-






In rounds 1-4, bound sequences were recovered by incubation at 95 °C. While this 
strategy maximizes recovery in early rounds, a key risk is that the aptamers gen-
erated will only bind to the immobilized version of the target molecule. Thus, for 
rounds 5-9, we partitioned bound sequences from the beads by elution with a so-
lution containing an excess of OTA, as this ensures that all sequences recovered 
are capable of binding to the unmodified target molecule. Additionally, since the 
attachment of the OTA to amine beads renders the phenylalanine region of the 
molecule less accessible, we expected that elution with free target molecule would 
allow for more interaction with this region of the molecule, and therefore enrich 
tighter binders. The recovered sequences from each round were incubated with 
DNase I prior to reverse transcription to eliminate any DNA template that was not 
effectively removed during the gel purification step. If this step is not performed, 
even a small amount of residual DNA will efficiently amplify during RT-PCR, com-
promising the ability to enrich the desired target-binding sequences. Importantly, 
this step was only possible because of our choice to utilize a TNA primer to gener-
ate a fully TNA library. Additionally, the use of a FAM-labeled TNA primer to gener-
ate our library enabled us to analyze the fraction of library recovered in each round 
using fluorescence spectroscopy. From these data, we monitored enrichment 
throughout the selection experiment (Figure 3.8). We observed a gradual increase 
in enrichment until round 5, at which point the slight decrease in percentage of 
library recovered was expected due to initiation of the ligand elution. This presum-
ably results because there is a fraction of the sequences that have been enriched 
to bind tightly to the immobilized target, but they do not bind to free OTA in solution. 
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Figure 3.8. Enrichment of OTA aptamers during TNA SELEX. 
Sequence recovery and screening of initial 
aptamer candidates 
We observed a considerable increase in library recovery at round 7, and 
carried out two additional selection rounds to determine whether these would result 
in further enrichment.  However, recovery appeared to show a slight decrease and 
then plateau with rounds 8 and 9. Despite the lower recovery in the last two rounds, 
we hypothesized that it would be valuable to compare the sequencing results 
across rounds 7, 8, and 9, as sequences that persisted through multiple rounds 
would have a higher probability of being genuine hits.  Using Sanger sequencing, 
25 clones from each round were analyzed, with the goal of identifying consensus 
within and between the final rounds of selection (Figure 3.9). We identified 10 se-
quences for which there were multiple copies in a single round, or which were 


















Figure 3.9 Sequences obtained from selection experiments. Letters A, B, and C 
correspond to clones from rounds 7, 8, and 9, respectively. Alignment was gener-




alignment.28 We purchased PEGylated DNA templates corresponding to each of 
these sequences, enabling their synthesis using enzymatic primer extension.  With 
these sequences in hand, we next turned to characterizing their binding affinity 
with the OTA target.  In choosing analysis method, a primary consideration was to 
avoid immobilization of the target molecule. As described earlier, immobilization of 
small-molecule targets can result in dramatic changes to chemical structure, and 
we were especially wary of carrying out of analysis using the same immobilization 
chemistry that had been employed in the selection rounds, as this could lead to 
false positive results.  MST appeared to be a promising approach, as it relies on 
the change in thermophoretic movement of a molecule in response to the addition  
of a binding partner, and does not require immobilization of either the receptor or 
target.29 Additionally, MST has sufficient sensitivity to detect even minor perturba-
tions, such as those caused by binding of a small-molecule target to a receptor, 
enabling us to place the fluorescent tag on the TNA strand and avoid modification 
of the OTA target.30 The MST data revealed that seven of the 10 TNA sequences 
showed binding to OTA, with five of these sequences having binding affinities in 
the nM range (Table 3.1 and Figure 3.10). Impressively, the two best TNA aptamers 
A04 and A07, were found to have KD values of 92 ± 2 and 96 ± 4 nM, respectively, 







Table 3.1. TNA sequences of potential aptamers and their corresponding KD val-
ues determined by MST. KD value for best reported DNA aptamer (A08) included 
for comparison. 
 TNA Sequence (3’à2’) KD (nM) 
A04 GCCGAGATTGCACTTACTATCTCAATAGGGTAAAAAAAAAAAGTTGGTCC-TATGGGTGGGTTGTTCAGTAATTGAATAAGCTGGTATGCGC 92 ± 2 
A07 GCCGAGATTGCACTTACTATCTGATGTTATTGTGTTTATTGGAATTTAAAGTATATGG-GATGTTTGGTTAGTAATTGAATAAGCTGGTATGCGC 96 ± 4 
A10 GCCGAGATTGCACTTACTATCTATTAGGAATAAGGTATGAATAGAGATGTATAAGTT-GTGTGGACGGTGTAATTGAATAAGCTGGTATGCGC 175 ± 29 
B02 GCCGAGATTGCACTTACTATCTCAAGAAGGGTAGTAAGAGGAGTGGGTGATTATGGG-TAAGTTGTATGAGGTAATTGAATAAGCTGGTATGCGC 1968 ± 139 
B17 GCCGAGATTGCACTTACTATCTGAAAGGGTGGAGATTGATAGGTATAGAGAAACGA-TAAGGGGGTGTAGAGTAATTGAATAAGCTGGTATGCGC -- 
B29 GCCGAGATTGCACTTACTATCTAAAGAAGAGTAGTAAGAGGCGTGGGTGATTATGGG-TAAGTTGTATGAGGTAATTGAATAAGCTGGTATGCGC 184 ± 7 
C06 GCCGAGATTGCACTTACTATCTGTTGAGGGAAGAAGTGGTGTAATGTGGAATAATT-GTTGTAATAGTAATTGATAAGCTGGTATGCGC 1414 ± 30 
C07 GCCGAGATTGCACTTACTATCTCATCAATAAAGATTATAGGGTGAAGGTGA-TAGTAGGTGGTATATAGGGTAATTGAATAAGCTGGTATGCGC -- 
C14 GCCGAGATTGCACTTACTATCTAAAGAAAGGTAGTAAGAGTGGGTGATTATGGG-TAAGTTGTATGAGGTAATTGAATAAGCTGGTATGCGC -- 
C22 GCCGAGATTGCACTTACTATCTCAAGAAGAGTAGTAAGAGGAGTGGGTGGTTATGAG-TAAGTTGTATGTGGTAATTGAATAAGCTGGTATGCGC 406 ± 79 
 DNA Sequence (5’à3’)  
DNA 




Figure 3.10. Binding isotherms for aptamer sequences determined by MST. 
Graphs are displayed as fraction bound versus OTA concentration. Each KD value 
and error is the average and standard deviation, respectively, of two trials.  
















































































































KD= 92 ± 2 nM
KD= 1414 ± 30 nMKD= 184 ± 7 nM
KD= 1968 ± 139 nMKD= 175 ± 29 nM
KD= 96 ± 4 nM
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Figure 3.10 continued. 





























































































KD= 172 ± 22 nM
KD= 98 ± 23 nM
KD= 71 ± 8 nM
KD= 406 ± 79 nM
DNA Aptamer A08












Determination of the minimal binding region for  
TNA aptamers 
 We next sought to determine the minimal binding region of the aptamers 
having the highest affinities.  A key goal in these experiments was to identify se-
quences that could be generated using chemical oligonucleotide synthesis, as this 
method is significantly more scalable than enzymatic synthesis, and thus is far 
preferable for future practical applications of our TNA aptamers.  In contrast to DNA 
synthesis, TNA synthesis presents a unique challenge in that both the phospho-
ramidite and alcohol coupling partners are attached to secondary carbon atoms.  
As a result, steric hindrance significantly decreases the coupling yield for each 
step, limiting the length of oligonucleotides that can be practically synthesized. In 
the case of DNA oligonucleotides, sequences of up to 200 nt can be routinely syn-
thesized, but chemical synthesis of TNA is currently limited to ~40 nt. Thus, of the 
five aptamers having nM binding affinities, aptamers A04 and B29 were chosen for 
our minimization studies, as secondary structure prediction suggested putative 
binding regions of <40 nt (Figure 3.11). In both of these sequences, the main struc-
tural elements are near the 3’ terminus (which is analogous to the 5’ terminus of 
DNA), allowing us to design initial truncations that could be enzymatically synthe-
sized using the same TNA primer that was employed in the SELEX experiments. 
For sequence A04, 37 nt were removed from the 2’ terminus to give A04T (54 nt), 
and for sequence B29, 51 nucleotides were removed from the 2’ terminus give 
B29T (43 nt). Initial screening using OTA-functionalized beads showed that both  





Figure 3.11 Rational truncation of aptamers A04 and B29 based on secondary 
structure predictions generated using Mfold. Outlined stem loop regions show min-
imized structures that were chemically synthesized using phosphoramidites. 
necessary encouragement to pursue chemical synthesis of sequences having fur-
ther truncations, and we synthesized the stem loop of B29 (B29Tmin, 35 nt) and 
loops 1 (A04T.1, 22 nt) and 2 (A04T.2, 31 nt) of A04, each having one additional 
flanking nucleotide on either side of the predicted structural element (Figure 3.11). 
Using MST analysis, we measured a KD value of 172 ± 22 nM for the 35 nt trunca-
tion B29Tmin, which is similar to that of the full length B29 aptamer, confirming that 
only the main stem loop is required for binding to OTA.  In the case of the A04-
derived sequences, we found that A04T.1 showed no binding to OTA, but the 31 
nt sequence A04T.2 bound OTA with a KD value 71 ± 8 nM.  This establishes that 
loop 2 of the sequence is the binding site for OTA, and it is interesting and fortuitous 
that the truncated sequence shows higher affinity than either the parent A04 apta- 
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mer or the A04T truncation containing both stem loops. Excitingly, the ability to 
generate the highest affinity aptamer using solid-phase synthesis provides a scal-
able route to acquiring material for use in diagnostic or therapeutic applications. 
Additionally, the ability to replicate affinity data between enzymatically and chemi-
cally synthesized oligonucleotides validates the faithfulness of information transfer 
between DNA and TNA in the selection and sequencing experiments. To our 
knowledge, this is the first example demonstrating this transition from enzymatic 
to chemical synthesis for a fully XNA aptamer. 
Biostability comparison of TNA and DNA 
aptamers with affinity for OTA 
In addition to quantifying binding affinity, we also sought to assess the sta-
bility of our aptamer in a variety of nuclease rich environments. The Chaput lab 
has shown that TNA has superior stability compared to RNA and other XNAs such 
as FANA when challenged with nucleases in biologically relevant matrices.32 How-
ever, there have been no reports that evaluate the ability of TNA aptamers to bind 
to their target molecule in these complex, nuclease rich environments. For these 
experiments, we challenged the highest affinity DNA aptamer and our best TNA 
aptamer (A04T.2) to increasingly harsh conditions including DNase I, 50% human 
serum in phosphate buffered saline (PBS), and 0.5 mg/mL human liver micro-
somes. Of these conditions, microsomes provide the most stringent test of nucleic 
acid stability due to the abundance of nucleases having differing activities and se-
quence preferences.32 Figure 3.12a shows that after incubation at 37°C for 3 d in 







Figure 3.12 Comparison of the biostability of FAM-labeled TNA aptamer A04T.2 
and DNA aptamer A08. (a) Denaturing PAGE analysis of the TNA (T) and DNA (D) 
aptamers after incubation in conditions of increasing nuclease stringency: selec-
tion buffer (control), 1.5 U DNase I, 50% human blood serum in PBS, and 0.5 
mg/mL human liver microsomes. Samples were incubated under these conditions 
for 3 days at 37 °C. (b) Bead-binding assay to determine retention of aptamer 
binding in the presence of nucleases. Each column and error bar represents the 



































intact with no degradation products detectable by denaturing PAGE.  After the nu-
clease treatment, each sample was incubated with OTA-functionalized beads to 
qualitatively assess whether the target-binding capability of the TNA and DNA ap-
tamers was retained. The binding data in Figure 3.12b support the PAGE results 
showing degradation of the DNA aptamer, as we observe significantly less binding 
after incubation in all three nuclease-rich conditions in comparison to the percent 
bound by a control DNA sample incubated only in buffer. In comparison, A04T.2 
shows a smaller change in binding capacity after incubation in DNase I, human 
serum, or liver microsomes. Given the high biological stability of TNA, we hypoth-
esize that the decreased binding that we do observe may be attributable to inter-
ference from the proteins and other molecules present in the serum and micro-
some matrices.  
Retention of binding in the presence of nucleases 
 To test this hypothesis, we returned to MST analysis to quantify binding af-
finity of the aptamers under biological conditions. Human serum is currently re-
garded as the standard for evaluating oligonucleotide stability and aptamer selec-
tivity, and therefore we preformed all experiments using 50% human serum in 
PBS. To avoid spectral overlap with the background fluorescence of the serum, 
Cy5 was employed in place of FAM for labeling the DNA and TNA aptamers in 
these experiments. Both aptamers were incubated in 50% human serum at 37°C 
for 3 d  or 7d, then MST measurements were acquired for each sample and com-
pared to results obtained earlier for each aptamer in buffer alone.  After incubation 




affinity (KD = 245 ± 35 nM), while the DNA aptamer shows a 16-fold reduction in 
affinity (KD = 2396 ± 539 nM) (Figure 3.13). We were surprised to not observe a 
greater reduction in binding affinity of the DNA aptamer after 3 days in serum, as 
our PAGE and bead-based experiments suggested near complete degradation of 
the DNA. However, there is evidence that terminal functionalization of nucleic acids 
can protect against degradation in serum, and given the sensitivity of MST, a bind-
ing isotherm can still be acquired even if only a small amount of intact aptamer 
remains.33 This notion is supported by the data acquired after seven days of incu-
bation in serum, as the binding affinity of aptamer A04T.2 remains unchanged (KD 
= 238 ± 29 nM), but the DNA aptamer shows no detectable binding to OTA, sug-
gesting complete degradation. The ability of our TNA aptamer to maintain target 
binding capability under such harsh conditions highlights the exceptional nuclease 
resistance of TNA polymers. Furthermore, the fact that the TNA aptamer binds to 
OTA with nM affinity despite the large excess of competing molecules in human 
serum suggests a high level of target binding selectivity.  
Conclusions 
 In summary, we have demonstrated in vitro evolution of the first XNA ap-
tamers capable of binding to a small molecule target. Our best TNA aptamers have 
low nM affinity for the OTA target, surpassing the affinity of the best reported DNA 
aptamer for the same target. We were able to successfully minimize two of the 
aptamer sequences to lengths of <35 nt, enabling them to be generated using 
solid-phase oligonucleotide synthesis. The 31 nt truncated sequence A04T.2 ex-
hibited the highest affinity of any sequence tested, and validates the integrity of  
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Figure 3.13 MST analysis of (a) TNA and (b) DNA aptamers binding to OTA after 
incubation in 50% human blood serum in PBS at 37 °C for 3 or 7 d. For both ap-
tamers, the binding affinity measured in selection buffer was used as the control. 
Error bars represent the standard deviation of two independent trials. 
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information transfer between enzymatically and chemically synthesized XNA.  We 
also show that the TNA aptamer is capable of binding to OTA after a 7-day incu-
bation in human serum, whereas the best DNA aptamer no longer functions after 
exposure to these conditions. Achieving success in these experiments required the 
expansion of XNA selection technology to enhance enrichment by suppressing the 
background arising from DNA contamination. We envision that this selection ap-
proach will be amenable to many interesting small-molecule targets, greatly ex-
panding the reach of XNA applications. Additionally, the demonstration that a TNA 
aptamer can be minimized to a length that is compatible with chemical synthesis 
provides access to significantly greater quantities of material, enabling new appli-
cations that were previously not feasible due to the limited practical scale of enzy-
matic synthesis.  For example, efforts are currently underway in our laboratory to 
engineer modified versions of our TNA aptamers into biosensors for use in toxin 
detection. We envision that these sensors will find high utility in field-based testing, 
where accurate quantitation of a desired target is needed with minimal sample 
preparation and using assays capable of enduring rigorous shipment and storage 
conditions.  Additionally, the ability of XNA aptamers to simultaneously provide high 
affinity, selectivity, and biostability suggests a bright future for these biopolymers 
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CHAPTER 4 




High-throughput screening (HTS) provides a powerful platform for drug dis-
covery through the in vitro quantification of small-molecule cofactors and metabo-
lites. For example, screening of GPCR targets and kinases is primarily accom-
plished through the detection of cAMP in cell extracts and ADP respectively.1,2 
Despite the promise of the HTS platform, there remain challenges for the develop-
ment of detection reagents, primarily in achieving specific molecular recognition of 
the target and the transduction of the binding event into an appreciable signal. 
Because only few reagents can fulfill both of these requirements, multiple steps 
are necessary in the assay design. Bellbrook’s EPIGEN assay for HMTs utilizes 
two enzymes to convert S-adenosylhomocystine (SAH) to AMP, which can then 
be subsequently detected using a competitive immunoassay where binding to the 
antibody displaces a fluorescent tracer which is measured as a change in fluores-
cence polarization (FP) signal (Figure 4.1).3 This enzyme coupling is necessary 




Figure 4.1. Coupled assay for detection of SAH produced by HMT enzymes. 
SAH product in the presence of an excess of the donor S-adenosylmethionine. 
Designing multi-step assays suitable for HTS often requires the identification and 
synthesis of multiple reagents in addition to the optimization of the integrated out-
put, making the process time and cost inefficient.   
 Although antibodies are the gold standard for HTS assays, they are not well-
suited for the quantification of small-molecule analytes due to their inability to dis-
criminate between structurally similar molecules. Functionalization of small mole-
cules is difficult to accomplish without modifying key recognition elements, which 
in part leads to poor selectivity. Further, conjugation to a carrier protein for antibody 
generation is challenging and may reduce the affinity and specificity of the anti-
bodies that are produced. Many assay formats (including FP) require conjugation 
of the small molecule to a reporter to serve as a competitor in the assay, resulting 
in similar synthetic challenges.  
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 One target of interest in the development of HTS assays is CoA which can 
be used for the measurement of histone acetyltransferase (HAT) activity (Figure 
4.2b). Because dysfunctional epigenetic regulation contributes to a variety of dis-
eases (neurological disorders, cancers, cardiovascular disease), HATs are being 
regarded as potential therapeutic targets.4-7 There is great interest in methods to 
detect CoA, a product of all HAT reactions, that will be advantageous over other 
techniques that detect specific acetylation events. There are 18 known human 
HATs with diverse substrate requirement, thus a universal detection platform for 
the detection of CoA would be of high utility. Importantly, measurement of HAT 
enzymatic activity requires specific recognition of CoA in the presence of excess 
acetyl CoA (AcCoA). Current commercially available assays rely on the reaction 
of a fluorescent probes with the free thiol in CoA which results in reduced fluores-
cence, however, this method suffers from frequent false positives and often few 
inhibitors are identified (i.e. 3 validated out of 1587 primary hits).8,,9 Other methods 
utilize coupled enzyme approaches with colorimetric output, however, these as-
says are insensitive, require great amounts of HATs, and are subject to interfer-
ence from the coupling enzymes.10  
 Nucleic acid aptamers are a promising alternative to antibodies as affinity 
reagents in HTS assays.11-14 Because SELEX doesn't require conjugation of the 
target molecule to a carrier protein,15,16 aptamers are more effective than antibod-
ies at discriminating minute structural differences between similar small-mole-
cules.17 Additionally, the in vitro method by which aptamers are generated is less 
expensive and results in less batch-to-batch variation. Importantly, aptamers can  
113 
Figure 4.2. Structure-switching biosensors for small-molecule detection. (a) SS 
biosensors provide a dose-dependent FP signal without labeling of the target. (b) 
Chemical structure of Coenzyme A (CoA).  
provide a direct fluorescence signal in a single step which obviates the need to 
functionalize the small-molecule target. One approach to aptamer-based detection 
is the structure-switching (SS) biosensor format, in which the aptamer is hybridized 
to a short complementary sequence to form a duplex in the absence of analyte.18,19 
Upon binding of the target, the complementary strand is displaced in a dose-de-
pendent manner. If the complementary stand is functionalized with a fluorophore, 
the displacement of the labeled strand causes a change in FP signal (Figure 
4.2a).20
Despite their potential for various applications, SS biosensors are not often 
utilized because many aptamers cannot be engineered into this configuration post-
selection. This is because the intention of the SELEX process is to identify se-
quences that bind a certain target, but success is not contingent on a target-de-
pendent conformational change. Consequently, only a few small-molecule binding 
aptamers (e.g. OTA, cocaine, ATP) are used for analytical applications because it 
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was discovered that they coincidentally undergo a conformation change upon bind-
ing.21 Recently, research effort has been focused on the development of SELEX 
methods that directly select for aptamers that exhibit this structure-switching be-
havior in the presence of analyte.22,23 All reported SS-SELEX methods are bead-
based and consequently suffer limitations related to interference due to the immo-
bilization of the library on a solid support.24 In bead-based SS-SELEX methods, 
the library is bound to a complementary strand that is attached to the solid support, 
and addition of the target results in the selective release of aptamers that function 
as structure-switching biosensors. However, a significant fraction of nonfunctional 
sequences are simultaneously eluted because hybridization to the complementary 
strand is in dynamic equilibrium. This phenomenon lowers the efficiency of the 
selection process, requiring more rounds (>10) of SELEX in order to observe sig-
nificant enrichment which is time-consuming and does not always successfully 
generate the SS biosensor construct.25 This obstacle is supported by the fact that 
in some cases traditional SELEX can produce aptamers, but current SS-SELEX 
methods fail to produce biosensors. The development of a more generalizable se-
lection method for the rapid and reliable generation of SS biosensors would be of 
great utility in the production of novel small-molecule detection platforms, and to 
the aptamers field in general.  
 We propose an innovative new method for the direct selection of SS bio-
sensors using a homogeneous PCR-based SELEX process (Figure 4.3). To carry  
out the proposed SS-SELEX method, we will use a DNA library with an N40 random 














to a short CS near the start of the random region on the 5¢ terminus. These se-
quences will be designed so that when the two strands are hybridized they form 
the double stranded palindromic recognition site for the EcoRI restriction enzyme. 
We chose this enzyme because it can provide essentially quantitative cleavage in 
a variety of buffer conditions. An important benefit over traditional bead-based 
methods is that the homogenous nature of this design allows the use of excess CS 
to prevent nonspecific dissociation of library members. Upon addition of the CoA, 
library members that function as SS biosensors will become dehybridized from the 
CS (functional), and those that do not bind the target or are capable of binding  
without releasing the CS will remain in a duplex (nonfunctional). In the presence 
of EcoRI restriction enzyme, nonfunctional sequences will be cleaved therefore 
removing one of the primer binding sites necessary for PCR amplification. Con-
versely, functional sequences that have successfully displaced the CS as a result 
of target-binding will not be digested and will remain intact. This allows us to se-
lectively amplify those sequences that function as SS biosensors which we can 
then purify to obtain the ssDNA for the next round of selection. To increase the 
selectivity of the SS biosensors we will perform a negative selection using acetyl 
CoA (AcCoA). We anticipate that our proposed SS-SELEX method will enhance 
enrichment of sequences that function as SS biosensors, requiring fewer rounds 
to obtain the desired SS architecture. We anticipate these SS biosensors will be 
optimized for the development fluorescence-based assay for histone acetyl HATs, 
as the proposed biosensor will based on a ligand-dependent FP signal. Further, 
we anticipate that SS-biosensors will be selective for CoA which will accommodate 
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HATs with high affinities for AcCoA. Together we predict these SS biosensors will 
be instrumental in the development of robust HAT enzyme assays. 
Results and discussion 
Screening possible restriction enzymes 
In the initial optimization of our library design we needed to identify which 
restriction endonuclease we would utilize for the cleavage step in our selection 
protocol. In choosing and enzyme, we narrowed our search down to those that had 
100% activity in a variety of buffer conditions and proceeded with BamHI and 
EcoRI.26 We designed two starting libraries having BamHI and EcoRI cut sites to 
assess and compare the efficiencies of both enzymes. We synthesized five short 
complementary sequences for each library ranging in length from 8-12 nt, which 
included the cut site for the restriction enzymes plus 2-6 additional bases on the 3’ 
end. Previous reports support that this DS length is sufficient for good hybridization 
but short enough to displaced upon target binding.27,28 In our first experiments, we 
hybridized both libraries to CS 8-12 and incubated these samples with their re-
spective restriction enzymes. We analyzed the efficiency of the digestion by dena-
turing PAGE to monitor percent cleaved. Fluorescence volumes were calculated 
for each band and percent cleaved was determined by the ratio of truncated prod-
uct to total band volume in a lane. Neither of these initial libraries showed any 
cleavage even after an overnight (~20 h) incubation. 
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Library design and optimization 
Upon further research, we discovered information suggesting that re-
striction endonucleases require flanking regions on their recognition sequences 
near the end of a DNA fragment for effective cleavage.29 Without a sufficient num-
ber of bases, the enzyme cannot properly dock onto the strand resulting in reduced 
efficiency. With this knowledge, we designed new CS sequences for two new li-
braries (EcoRI and BamHI libraries) which incorporated 1-3 flanking regions on 
either side of recognition site resulting in three strands that were 8, 10, and 12 nt 
in length (Figure 4.4a). We included a 14 nt CS for the BamHI library because the 
enzyme is slightly less efficient than EcoRI and longer sequences are needed for 
complete digestion. Excitingly, we observed cleavage of both libraries by their re-
spective enzymes with efficiencies of 78% with the 8 nt CS and 85-90% for the 
longer CS sequences (Figure 4.4b). This difference in yield is expected as longer 
sequences are expected to improve efficiency. Although the ability of the enzymes 
to cleave their respective libraries were comparable, the efficiencies were slightly 
higher for EcoRI at all CS lengths. Therefore, we decided to move forward with 
EcoRI as our restriction endonuclease for optimization and ECS 12 which had the 
highest efficiency (90%). 
Maximizing cleavage efficiency 
While we were excited to observe such high percentages of cleaved library, 
our selections require that this efficiency be as close to 100% as possible. During 
our selection we will monitor enrichment by quantifying the percent of library that 




Figure 4.4. Optimizing library and digest conditions. (a) Library and CS sequences 
for both BamHI and EcoRI with recognition sequence in blue. CS sequences listed 
under library to illustrate cut site. (b) Digestion of libraries using CS with flanking 
regions. Library/DS complexes were incubated with enzyme for 2 hrs and analyzed 
by PAGE to quantify % cleaved. 
be degraded. Any nonfunctional library members that remain uncleaved as a result 
of incomplete digestion have the potential to dominate the sequence pool and 
make it more difficult to identify functional sequences. As such, the digestion of our 
library using EcoRI needs to be optimized prior to beginning selection. We hypoth-
esized that the reduced efficiency of the EcoRI digestion could be attributed to 
library members which possess inherent secondary structure that prevents the hy-
bridization of the CS. Although these sequences don't undergo a conformational 
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change upon target binding, they will be propagated to the next selection making 
it difficult to enrich sequences that function as SS biosensors. To test this theory, 
we ordered a sequence with minimal predicted secondary structure which we call 
“EcoRI test sequence” (Figure 4.5a). We hypothesized that if it was inherent sec-
ondary structure that was inhibiting hybridization to the displacement strand, the 
use of this test sequence would allow for efficient hybridization, resulting increased 
cleavage efficiency.   
We tested the ability of EcoRI to cleave this test sequence using a 1:1 and 
1:2 ratio of the library to ECS 8, 10, and 12.  As evident in Figure 4.5b, we saw no 
improvement upon the 90% cleavage efficiency we observed using the library even 
after a 20 h incubation period. Despite this result, we remained convinced that it  
Figure 4.5. Cleavage of EcoRI control sequence. (a) Secondary structure 
prediction for EcoRI test sequence. (b) Digestion of test sequence using different 
CS lengths, ratios, and incubation times. 
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was in fact prohibitive secondary structure preventing complete digestion of our 
library. We proposed another idea to validate this claim using magnetic beads 
functionalized with the CS. We hypothesized this would be a clever way to sepa-
rate sequences that can effectively hybridize the CS. We modified the 12 nt CS 
with an amine on the 3¢ terminus to enable attachment to carboxylic acid function-
alized magnetic beads (Figure 4.6a). Since the CS is complementary to the part of 
the library closest to the random region, we also added two PEG spacers in be-
tween the CS and terminal amine to ensure that there would be no steric hindrance 
preventing the library from hybridizing to the beads. Additionally, we included a 
photocleavable (PC) spacer in front of the DS to allow recovery of the library/CS  
 
Figure 4.6. Elimination of sequences with prohibitive secondary structure. (a) 
Conjugation of photocleavable CS to magnetic beads and hybridization of library 
to form biosensor complex attached to beads. (b) Digestion of library/CS complex 
by EcoRI after recovery from beads by UV irradiation. 
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complex from magnetic beads. We incubated our library with the CS-beads, and 
once hybridized we performed a series of washes in order to remove nonbound 
sequences. We then used UV light to remove the biosensor complex which was 
subsequently used in an EcoRI digestion reaction. We were pleased to observe 
that 99% of our library was cleaved using this bead step (Figure 4.6b). We deter-
mined that this new level of efficiency we achieved using this step would be suita-
ble for our selections. This confirmed that the certain sequences are problematic 
for the generation of biosensors using our proposed method and can be effectively 
removed using the aforementioned bead step. Further, we anticipate that the in-
clusion of this step in the first round of our SELEX method will aid in reducing any 
bias that may affect the efficacy of the selection.  
Reducing bias during selection 
One important question we wanted to answer is what happens to the <1% 
of library that doesn't get cleaved over the SELEX process, as we believe that it 
has the potential to bias the enrichment of nonfunctional sequences. We hypothe-
sized that we could gain valuable information if we performed the bead step we 
developed, PCR amplified the uncleaved portion of the library, and attempted to 
re-digest this material (without prior bead step). This would allow us to verify that 
we don't reintroduce bias after amplification and also to estimate whether we need 
to perform the bead step every round. After completing the bead method to hybrid-
ize and recover the library/CS complex, the remaining ~1% of uncleaved library 
was amplified and purified. This purified library was then hybridized to ECS 12 at 
a 1:2 ratio in solution and incubated with EcoRI. We were pleased to observe <0.1% 
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of the library remained uncleaved which further validates the benefit of including 
the bead step prior to digestion. This result suggests that the beads will only be 
required in the first round as we are able to retain highly efficient digestion of the 
library after amplification and re-digestion. However, we concluded that it would be 
beneficial to include this step every three rounds to provide a convenient method 
to eliminate any bias that may develop. Importantly, because selection step will 
occur after the biosensor complex is recovered from the magnetic beads, we are 
able to maintain the homogenous nature of our proposed SS-SELEX method. 
PCR optimization 
 In preparation for selection, it was important to carefully consider the condi-
tions for PCR amplification. The library in this study present a unique challenge 
due to the fact that there is the restriction site within the 5’ primer binding site of 
the library which will also be present in the forward primer for PCR. Because the 
recognition sequence is a palindrome, the forward primers are likely to form dimers 
which can be problematic during PCR amplification. While some off-target product 
during PCR will not be detrimental since we will perform a gel purification after 
amplification, we wanted to minimize the propensity for primer dimers to ensure 
our potential aptamers can be effectively enriched during PCR. Using too much 
primer in PCR reactions increases the probability that they will bind to eachother 
to form dimers and also to nonspecific sites on the template.30 In addition, increas-
ing the annealing temperature can increase the specificity of primer binding in or-
der to mitigate the formation of primer dimers. Therefore, we began the optimiza-
tion of our PCR protocol by using a range of primer concentrations and annealing 
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temperatures and assessing the fidelity of library amplification (Figure 4.7a). We 
used three annealing temperatures (55°C, 60°C, 65°C) and three primer concen-
trations (50 nM, 100 nM, and 200 nM) in various combinations and analyzed the 
results by denaturing PAGE. We observe that at higher concentrations of primer 
and lower annealing temperatures we see multiple bands likely resulting from pri-
mer dimers and nonspecific hybridization to the library. We obtained relatively 
clean product at 50 nM primer and an annealing temperature of 60°C and decided 
to use those conditions during selection. While we observe reduced yield with 
these conditions we expect that this can be compensated for by increasing the 
number of PCR reactions we perform. There have been reports that organic addi-
tives can improve PCR amplification by enhancing specificity to increase the yield 
of full length product.31,32 We tried various combinations of betaine, DMSO, and 
1,2-propanediol which are all additives that have been validated to improve PCR 
fidelity (Figure 4.7b). We do observe the reduction of nonspecific products with the 
combination of 1.25 M betaine and 5% DMSO (lane 5), when compared to the 
control (lane 1). However, this increased specificity occurs at the cost of yield as 
the bands appear proportionally faint. We concluded there would be no incremen-
tal benefit to including additives, and that the modifications to the annealing tem-
perature and primer concentration provide sufficient specificity for selection.  
SELEX method and progress 
 In addition to eliminating some nonfunctional sequences, we hypothesized 
that the CS-bead step would provide a convenient way to perform a negative se- 




Figure 4.7. PCR optimization using EcoRI library. (a) Optimization of annealing 
temperature and primer concentration for PCR of EcoRI library. (b) Exploring the 
effect of PCR additives (0.8 M 1,2-propanediol, 1.25 M betaine, and 5% DMSO) 
on yield of full-length product.  
zed to the CS-beads for an hour incubation. Any sequences that undergo a con-
formational change due to binding of AcCoA, will be separated from the remaining 
library members using a magnetic stand. This allows us to remove any sequences 
that bind AcCoA, so that we enrich those sequences that function selectively as 
SS biosensors for CoA. We began our positive selection at 1 mM CoA in the first 
round and plan to reduce the concentration once we observe enrichment. Reduc-
ing the concentration of the CoA will enable us to select for aptamers with better 
affinity for the target. In round 3, we introduced the negative selection to the bead 
bound library/DS complex using 100 µM AcCoA. We increased this amount to 250 
µM AcCoA in round 6 to increase the stringency of our negative selection and we 
plan to gradually increase the AcCoA amount to 1 mM over subsequent rounds. 
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We expect that challenging the library to an equivalent concentration of off-target 
as where we initiated our positive selection will allow us to select for biosensors 
that have superior selectivity. We have completed six rounds of selection to date, 
and while we have not observed significant enrichment, we believe these results 
look promising (Figure 4.8). There is a decrease in percent uncleaved library in 
round 3 which we would expect due to the introduction of the negative selection. 
We are encouraged that the subsequent rounds of selection all exhibit higher per-
cent uncleaved than round 1, supporting that we are successfully enriching our 
library. Further, it is promising that we observe higher enrichment in round 6 com-
pared to round 3, even with the increased stringency of the negative selection. 
Conclusions 
We propose a novel PCR-based SELEX method for the generation of SS-
biosensors. In this protocol, functional sequences be digested by a restriction en-
zyme and will be selectively amplified by PCR. We anticipate that this method will 
Figure 4.8. Progress for the selection of SS biosensors for CoA. Enrichment is 
monitored by the amount of uncleaved library reamaining after EcoRI digestion. 
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be advantageous as the selection step does not require the use of a solid support. 
This will overcome the limitations of traditional bead-based SS-SELEX methods 
such as nonspecific elution and retention of nonfunctional sequences, and allow 
for high partitioning and enrichment. We have carefully designed our SELEX library 
to enable digestion by restriction enzyme when hybridized to a short CS. We have 
chosen EcoRI for our method, and have optimized conditions for maximal digest 
efficiency and PCR amplification of our library. We anticipate that together these 
optimized conditions will lead to reduced bias during our selection and effective 
enrichment of sequences that function as SS biosensors. We are encouraged by 
our SELEX progress thus far, and are confident this method holds promise for the 
generation of selective, high affinity biosensors for the detection of CoA. We are 
optimistic that SS biosensors for CoA generated by our innovative method will be 
of high utility in the development FP-based assays for HAT detection. Further, we 
anticipate that successful implementation of this novel SELEX method will provide 
a generalizable evolution strategy to develop SS biosensors to a variety of small-
molecule targets, and streamline the development of aptamer-based biosensors 
for diverse applications.  
Materials and methods 
Oligonucleotides synthesis 
All DNA sequences were purchased from the University of Utah DNA/Pep-
tide Synthesis Core Facility. All oligonucleotides were purified by denaturing PAGE 
and the desired band was excised and incubated in crush and soak buffer (300 
mM ammonium acetate, 1 mM EDTA, pH 8.0) at 40°C overnight. Samples were 
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separated from gel pieces and buffer exchanged into water using Amicon Ultra-
0.5 Centrifugal Unit with Ultracel 10 membrane (EMD Millipore). 
Functionalization of photocleavable CS to magnetic beads 
 400 μl of M-270 carboxylic acid beads (Life Technologies) were washed 
three times with 1 mL 25 mM MES, pH5. After each wash, the beads were sepa-
rated from the supernatant using a magnetic separation stand (DynaMag-Spin, 
Life Technologies). 8400 pmol of PC-DS12 (AATGAATTCTGA/PC 
spacer/Sp18/amine) was suspended in 240 μl of 25 mM MES buffer, pH 5 and 
mixed with the washed beads and incubated for 30 min at room temperature with 
slow tilt rotation. After equilibration to room temperature, EDC was dissolved in 
cold 100 mM MES, pH 5 to a final concentration of 100 mg/mL. 120 μl of the EDC 
solution was added to bead/ligand mixture and mixed well. The beads were 
brought to a final volume of 400 μl with 25 mM MES, pH 5 and incubated at 4°C 
overnight with slow tilt rotation. The functionalized beads were washed three times 
with 1 mL 1X EcoRI buffer (100 mM Tris-HCl, 50 mM NaCl, 10 mM MgCl2, 0.025% 
Triton X-100, pH 7.5) and re-suspended in 500 μL of this buffer for storage at 4°C. 
Successful attachment of PC-DS12 was validated by monitoring absorbance at 
260 nm. 
Hybridization of library to CS-beads and recovery  
of biosensor complex 
 5 pmol of EcoRI.3 library were added to 10 μL (2 x107) of /PC/ECS 12 func-
tionalized beads to a final volume of 100 μL in 1X EcoRI buffer. The library was 
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hybridized to the DS-beads by heating to 95 °C for 5 min, cooling at 4 °C for 10 
min, and a final incubation at 25 °C overnight, the beads were then washed three 
times with 200 μL EcoRI buffer and resuspended 100 μL (having an extra equiva-
lence of ECS12. The biosensor complex was cleaved from the beads by exposure 
to UV light (365 nm) for 45 min. This step was performed in a 4°C refrigerator to 
minimize dissociation of the library and CS. 
EcoRI digest of biosensor complex 
The library/DS complex was divided into 10 μL portions and 1.5 U EcoRI 
(New England Biolabs) was added to each aliquot.  The solutions were incubated 
for 2 hrs at 37°C. The EcoRI was denatured for 20 min at 65°C and the library was 
recovered using a minelute PCR cleanup column (Qiagen). Samples were ana-
lyzed by denaturing PAGE on a 10% polyacrylamide gel to monitor digestion of the 
library. The gels were imaged using a blue laser (473 nm)/long pass blue filter and 
fluorescence volumes were calculated for all lanes. Digest efficiency was deter-
mined by the percent cleaved (fluorescence band volume for the cleaved product/ 
total lane volume). 
PCR amplification of library after digest 
 A single stranded DNA library having the sequence 5’- CGCAT-
ACCAGCTTAGTTCAGAATTCATT-N40-AGATAGTAAGTGCAATCTCGGC -3’ (20 
pmol) was amplified in 50 μL PCR reactions containing 0.2 μM template, 0.05 μM 
each primers, 200 μM dNTPs, and 2.5 U Taq DNA polymerase in 1x Thermopol 
buffer (20 mM Tris-HCl, 10 mM (NH4)2SO4, 10 mM KCl. 2 mM MgSO4, 0.1% Triton 
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X-100, pH 8.8, New England Biolabs). The forward primer had the sequence 5’-
/FAM/CGCATACCAGCTTAGTTCAGAATTCATT-3’ and the reverse primer had 
the sequence 5’ TTTTTTTTTTTTTTTTTTTT/Sp9/GCCGAGATTGCACTTACTA-
TCT -3’. PCR was carried using a program with an initial denaturation at 95°C for 
3 min, 12 cycles of (95°C for 30 s, 60 °C for 30 s, and 72 oC for 20 s), and a final 
extension 72 oC for 2 min. The amplified double stranded DNA was purified using 
a PCR cleanup column (Qiagen) and the PEG-functionalized strand was separated 
from the FAM labeled strand on a denaturing 10% polyacrylamide gel. FAM-la-
beled ssDNA library was recovered by elution in crush and soak buffer as men-
tioned previously. Samples were recovered using size-exclusion centrifugal units 
as described previously.  
PCR-based SS-SELEX 
The purified DNA library (~1014 sequences) was folded in 1X EcoRI buffer 
in a total volume of 100 μL by heating to 95 °C for 5 min, cooling at 4 °C for 10 
min, and a final incubation at 25 °C for 10 min. CoA was added to the solution at a 
final concentration of 1 mM and incubated for 1 h at 25 °C. For the negative selec-
tion every three rounds, the library was hybridized to the CS-beads and incubated 
with the desired concentration AcCoA (start at 100 µM). The off-target binding se-
quences were removed by washing three times with 100 μL 1X EcoRI buffer, using 
the magnetic stand to separate the supernatant from the beads. The beads were 
resuspended in 100 μL binding buffer and the bound sequences were recovered 
by exposure to UV light as previously described. 1.5 U EcoRI was added to the 
mixture and incubated for 2 h at 37 °C. Enrichment was monitored as the amount 
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of uncleaved material that remained postdigestion. The restriction enzyme was 
purified using a PCR cleanup column and the recovered DNA was amplified using 
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	CHAPTER 5 
CONCLUSIONS AND FUTURE DIRECTIONS 
Conclusions 
 We have described novel selection methods to generate enhanced func-
tional nucleic acids for the development of aptamer based-biosensors. We have 
implemented a IP-SELEX method to generate self-alkylating ribozymes for fluo-
rescent mRNA labeling. These ribozymes are capable of catalyzing the covalent 
attachment of a small-molecule fluorophore to itself. Further we show that the ri-
bozyme can be fused onto a longer mRNA sequence and successfully react with 
the label in simulated physiological conditions. We anticipate these ribozymes will 
prove advantageous over previous noncovalent small-molecule binding aptamers 
for live cell labeling. We have designed a novel selection method for the generation 
of TNA aptamers to OTA. Our ability to utilize a TNA primer allowed for the elimi-
nation of contaminating DNA which aided in the efficient enrichment of TNA ap-
tamers. This method enabled us to generate the first XNA aptamer of any kind to 
a small-molecule target. Further, we exhibit the impressive stability in the presence 
of nucleases and their ability to retain ligand-binding in these conditions where 
comparable DNA aptamers fail. Last, we introduce an innovative PCR-based 
SELEX method for the generation of SS biosensors to CoA. In this protocol, PCR
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amplification serves as the step to selectively enrich functional sequences, obviat-
ing the need for a solid support for selection. We have optimized library design to  
include an EcoRI cut site to allow the efficient digestion of non-functional se-
quences. We anticipate this technique will be generalizable for any small-molecule 
target, and successfully generate the SS architecture that can be easily developed 
into a fluorescence assay for detection. These data support in vitro evolution as a 
powerful technique to generate molecular recognition elements, which can be ex-
panded upon to attain aptamers with unique function and attributes. Through the 
methods discussed we have generated nucleic acids polymers with enhanced 
functionality such as nuclease resistance, covalent attachment of a label, and priv-
ileged architectures that hold great promise as biosensors. We are encouraged by 
the results we have attained thus far, and are excited to move forward into further 
optimization of these systems. Upon further studies, we are enthusiastic about the 




 While we are excited by the results we have obtained with our current ribo-
zymes we have developed, we have several modifications to the SELEX protocol 
for the generation of our second-generation ribozymes. There are some aspects 
of our original selection method that may have biased generation of ribozymes that 
have low affinity for the FIA. Small-molecule binding RNA aptamers typically have 
high nM to low µM range1,2, and we hypothesize that ribozymes with high affinity 
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were lost in the selection process. We plan on reducing the random region form 
N116 to N50, as this length has been shown to be successful in the generation of 
ribozymes.3,4 This will result in shorter ribozymes that will be more functional for 
imaging as they will be less likely to perturb the target mRNA sequence.  Addition-
ally, we will decrease the concentration of fluorophore form 200 µM to 1 µM over 
the course of the selection to bias towards ribozymes that have low micromolar 
affinities.  The IP step will be carried out in 0.1X PBS buffer and 2M urea to disrupt 
RNA-fluorophore binding and permit more efficient pull-down of sequences that 
bind tightly to the fluorophore.  
 In addition to modification to the SELEX protocol, we will generate second-
generation ribozymes using alternative fluorophore, electrophiles, and linkers 
shown in Figure 5.1. We will use both fluorescein and malachite green (MG) as 
they have advantages for different applications. Fluorescein, which is constantly 
fluorescent, is ideal for pulse-chase experiments as it is necessary to verify fluor-
ophore washout from cells. MG is fluorogenic5 and will provide reduced back-
ground as signal will only be generated when bound to the target transcript. Wag-
oner, Bruchez, and coworkers have demonstrated that MG analogues with short 
side chains are cell permeable, do not bind nonspecifically in cells, and have low 
cytotoxicity.6,7 Additionally, the emission wavelength of MG bound to activating 
RNA is in the range of 650-680 which will minimize signal overlap from cell auto-
fluorescence.8 We realize that the use of FIA was not well-suited for living cells as 
iodoacetamides are strong electrophiles that can react with molecules readily pre-
sent in cells (i.e., thiols from proteins and glutathione,) and increase background  
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Figure 5.1. Structures of alternative fluorophores and electrophiles to be used for 
second-generation ribozyme selection 
fluorescence. Thus, we will use bromoacetamide (BA) and sulfonium (SF) as al-
ternative electrophiles.  We were motivated to use BA as it is a weaker electrophile 
leading to attenuated reactivity and is anticipated to show selectivity for nitrogen 
nucleophiles.9 The use of SF was bio-inspired by the role S-adenosylmethionine 
(SAM) plays in the alkylation of DNA and RNA,10,11 however, only has minimal 
reactivity with cellular nucleophiles when unassisted by an enzyme. Further, we  
will increase the length of the linker between the fluorophore and electrophile in 
order to improve access to nucleophiles on the RNA.   
We have previously discussed that our ribozymes generated by IP-SELEX 
are uniquely suited to enable identification transcript-specific RNA-binding proteins 
using our proposed TRIP methodology (Figure 5.2). Because our self-alkylating 
ribozymes covalently attach fluorescein to the target RNA transcript and can be 
efficiently captured by antibodies, they are ideal pull-down assays. New RNA reg- 
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Figure 5.2. Transcript-specific immunoprecipitation (TRIP) to identify ZBP-1 
bound to b-actin mRNA 
ulatory mechanisms are often discovered by expression studies where the proteins 
responsible for the phenotype are unknown, and thus our proposed TRIP method 
holds great promise. Further, we have shown that ribozyme 5FR1 is able to self-
label in the crosslinking conditions necessary for IP protocols. We aim to demon-
strate pull-down of the well-studied zipcode-binding protein (ZBP-1), which is 
known to bind to the 54 nt “zipcode” sequence in the the 3¢ UTR of b-actin mRNA.12 
Once ZBP-1 is recruited by b-actin mRNA, the transcript is localized to the leading  
edge of fibroblast cells.12 As shown in Figure 5.2, we will fuse the ribozyme to b-
actin mRNA and subsequently express this fusion in cells. These cells will then be 
incubated with formaldehyde to crosslink RNAs with their bound proteins, lysed, 
and then FIA will be added to the lysate. Antibody-functionalized magnetic beads 
will then be used to pull-down RNAs that were successfully labeled. RNA-protein 
complexes will be removed from the beads using RNAse and the crosslinks will be 
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reversed to dissociate the protein. The proteins will be analyzed by gel electropho-
resis and Western blotting will be used to detect ZBP-1 or LC/MS/MS when the 
protein is unknown. 
Nuclease-resistant TNA aptamers 
In the short-term future of this project, we have ongoing research in the lab 
towards the development of a SS biosensor using our TNA aptamer A04T.2 for the 
detection of OTA. Analysis of OTA is currently accomplished by chromatographic 
methods such as thin-layer chromatography (TLC), HPLC, and GC-MS.13 These 
techniques require training and specialized equipment, and extensive sample 
preparation in order to attain sensitive detection. There have been several reports 
of aptamer-based sensors for OTA, however, these require extensive modifica-
tions to generate signal and do not function in complex samples.14,15 In the search 
for a fast a reliable alternative, Zeng and coworkers developed fluorescence-based 
assay for the detection of OTA using a SS-signaling DNA aptamer.16 Using this 
method, they were able to detect OTA down to 0.8 ng/mL and in addition could 
recover toxin in corn samples. Despite this promise for detection in food samples, 
indication of prolonged exposure to OTA is measured in human blood se-
rum/plasma where DNA will likely degrade.17 We anticipate that a SS biosensor 
composed completely of TNA will be advantageous as the high stability will expand 
the potential matrices the biosensor will function in. We plan to initially construct 
CS strands of different lengths and optimize the site of hybridization on the ap-
tamer in order to maximize fluorescence enhancement. While there is a possibility 
aptamer A04T.2 will not function as a biosensor as we did not directly select for 
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this architecture, we are encouraged that the DNA aptamer for OTA was engi-
neered successfully post-selection for SS activity. 
 We hypothesize that the impressive stability of our TNA aptamers will be 
advantageous for real-world applications where natural nucleic acids are limited. 
As previously discussed, small-molecule toxins can pose a serious threat, however, 
simply detecting the concentration of toxin is insufficient. Because the biological 
response to toxins can occur quickly18, prophylactic therapy which that could be 
given in advance to remedy potential exposure would be extremely beneficial. 
Macromolecular affinity reagents provide a promising approach as they can adsorb 
toxin that enters the bloodstream. Traditional receptors (antibodies, DNA/RNA) are 
problematic for this purpose as they are readily degraded by nucleases and prote-
ases, therefore our TNA aptamers are a promising alternative due to their remark-
able stability and low immunogenicity. We have described that these aptamers are 
capable of binding OTA with high affinity, however, they are not optimized for treat-
ment alone due to limitations such as circulation lifetime and persistence of binding. 
We propose that the attachment of TNA aptamers to the interior and exterior of 
virus-like particles (VLPs) will be a powerful tool for toxin sequestration (Figure 5.3). 
VLPs have shown great promise over delivery vehicles as they can be easily func-
tionalized and protect their cargo from degradation.19 We anticipate the benefits of 
using VLPs will be two-fold: to enhance circulation lifetime and also allow multiva-
lent display of the aptamer for more effective retention of sequestered toxin. We 
expect that the exterior aptamers will provide fast capture, and if the toxin becomes 
unbound over time it is likely to diffuse through the pores into the interior of the  
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Figure 5.3. Rapid capture by surface aptamers on VLPs followed by diffusion to 
interior, which provides longer term sequestration. 
VLP. The effective concentration of aptamers will be higher in the interior to enable 
long-term capture and sequestration. We will express the monomeric subunit of 
the cowpea chlorotic mottle virus (CCMV) having an azide-functionalized amino 
acid on the interior or exterior surface of each monomer (Figure 5.4).  Alkyne-
functionalized TNA aptamer will be conjugated to the monomers using copper cat-
alyzed azide-alkyne cycloaddition (CuAAC). The aptamer modified monomers will 
be combined with unmodified monomers in varying ratios to assemble the VLPs in  
vitro. We will measure the binding affinity and kinetics of the aptamer-functional-
ized VLPs to gain insight into how aptamer behavior is altered once attached. We 
will also perform dialysis experiments to determine the rate of sequestration and 
persistence of binding of the VLPs in solutions of OTA. We expect that we will gain 
fundamental knowledge regarding binding capacity, sequestration rate, and mech-
anism of the aptamer-functionalized VLPs. We envision this will be a powerful 
method for advanced treatment of toxin exposure.  
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Figure 5.4. Synthesis and assembly of aptamer-VLP conjugates. 
Structure-switching biosensors 
Once we generate SS biosensors for CoA, we will integrate these biosen-
sors into a HAT enzymatic assay with an FP readout (Figure 5.5). FP assays are 
the simplest fluorescence molecular binding assay because they only require la-
beling of one component and signal is not dependent on proximity between fluor-
ophores. FP is traditionally used in a competitive format where the ligand displaces 
a small, fluorescent tracer from the receptor molecule, which causes a decrease 
in polarization. Using our SS biosensors, a fluorescently labeled CS will dissociate 
from the aptamer and the fluorophore will undergo a decrease in FP. We anticipate 
that optimizing the fluorophore attachment and relative sizes of the aptamer and 
CS will enable an appreciable FP signal in response to low levels of CoA and in 
the presence of excess AcCoA. FP has been accomplished using the direct meas-
urement of fluorophore labeled aptamer, however, this method is limited to inter-
actions where the target is much larger.21 Because the rate of rotation of a mole-
cule is highly dependent on molar mass of the molecule being measured, FP as-
says are more challenging for small molecule targets.22 SS biosensors are advan-
tageous for FP assays as the additive effects of changes to the fluorophore micro- 
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Figure 5.5. SS-biosensors for small-molecule detection. (a) Structure-switching 
biosensors provide a dose-dependent FP signal without labeling of target. (b) 
Chemical structure of Coenzyme A.	
environment and size resulting from the binding-induced dissociation will enhance 
the polarization signal.14 After identifying the best FP constructs using the CoA SS 
biosensors we selected using our PCR-based SELEX method, we will test these 
for the detection of purified HATs. There are a two HATs, including PCAF and 
CGN5, which have been validated in coupled enzyme assays for CoA detection, 
and will serve as a validation of the of our biosensors. These samples will be ana-
lyzed using a fluorescence plate reader, and standard curves will be constructed 
to convert FP signals to the amount of CoA formed.  
 Importantly, we anticipate that this method will be generalizable to enable 
the generation of SS biosensors to a variety of targets. Hence In the future we 
anticipate our SELEX method can be used to develop SS biosensors for small-
molecule enantiopurity measurement to accelerate biocatalyst discovery. Stere-
oselective catalysis is vital to synthetic organic chemistry,22 and while naturally 
 145 
occurring enzymes remain the most efficient catalysts, they are not optimized for 
specific chemical transformations.23 Highly selective enzymes can be evolved 
screening a large library of mutants to screen for those that provide the highest 
stereoselctivity.24 This is usually analyzed by chiral chromatography or mass spec-
trometry, which are both limited in their sample throughput. Our group has recently 
shown that SS-biosensors composed of naturally occurring D-DNA and enantio-
meric L-DNA can be used simultaneously to enable enantiopurity measurement in 
solution.25 The principle of reciprocal chiral substrate selectivity states that an ap-
tamer synthesized from opposite enantiomers of DNA will form mirror image com-
plexes that bind to opposite enantiomers of a target with the same affinity and 
selectivity (Figure 5.6 a,b).26 Our lab has recently developed enantiomeric sensors 
using the previously reported DNA SS biosensor for L-tyrosynamide (L-tym). As 
shown in Figure 5.6c, these sensors could be modified with spectrally orthogonal 
fluorophores to enable simultaneous measurement of L-tym and D-tym concentra-
tions in the same solution.24 These measurements can be performed in a microwell 
plate which has the potential to dramatically increase the throughput of analysis. 
Looking ahead to enzyme evolution, we were intrigued by 2-chloromandelic acid 
(2-CMA) as an interesting target since it is a key intermediate in the synthesis of 
the drug Plavix (Figure 5.7a).26 Arnold and coworkers have demonstrated that 
P450 enzymes can be used to generate the S-enantiomer of mandelic acid esters 
with 57-94% enatiomeric excess (ee) (Figure 5.7c).27 Our group has regarded 2-
CMA as a compelling target to verify the power of our screening methods, as en-
zyme variants could potentially improve the enatioselectivity to >99 %ee. Past 
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Figure 5.6. Enantiomeric DNA biosensors. (a) Chemical structure of D- and L-DNA. 
(b) D- and L-DNA aptamers each bind to a different enantiomer of the small-mole-
cule target to produce mirror-image complexes. (c) Enantiomeric SS biosensors
modified with orthogonal fluorophores enables simultaneous quantification of both
enantiomers of a target.
members have generated aptamers that bind S-2-CMA over R-2-CMA with greater 
than 1000:1 selectivity using traditional bead-based selections.28 Despite these 
encouraging results, none of these aptamers were able to produce a structure-
switching response in the presence of target. We anticipate that our newly devel-
oped PCR-based SS-SELEX method will overcome this obstacle to successfully 
and reliably generate SS biosensors. The ability to develop biosensors with the 
desired architecture to a variety of targets has the potential to greatly accelerate 
enzyme evolution and the discovery of highly efficient catalysts via our robust en-




Figure 5.7. Synthetic schemes involving 2-chloromandelic acid. (a) 2-CMA is a 
key intermediate in the synthesis of clopidogrel. (b) Enzymatic synthesis of R-2-
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